Nextgen Healthcare (NXGN) 10-Q 29 Oct 21 2022 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Sep. 30, 2021	Oct. 26, 2021
Cover [Abstract]
Entity Registrant Name	NEXTGEN HEALTHCARE, INC.
Trading Symbol	NXGN
Entity Central Index Key	0000708818
Document Type	10-Q
Document Period End Date	Sep. 30, 2021
Amendment Flag	false
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q2
Current Fiscal Year End Date	--03-31
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Shell Company	false
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Entity File Number	001-12537
Entity Tax Identification Number	95-2888568
Entity Address, Address Line One	3525 Piedmont Rd.
Entity Address, Address Line Two	NE
Entity Address, Address Line Three	Building 6, Suite 700
Entity Address, City or Town	Atlanta
Entity Address, State or Province	GA
Entity Address, Postal Zip Code	30305
City Area Code	(404)
Local Phone Number	467-1500
Entity Interactive Data Current	Yes
Title of 12(b) Security	Common Stock, $0.01 Par Value
Security Exchange Name	NASDAQ
Entity Incorporation, State or Country Code	DE
Document Quarterly Report	true
Document Transition Report	false
Entity Common Stock, Shares Outstanding		68,387,405

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2021	Mar. 31, 2021
Current assets:
Cash and cash equivalents	$ 75,303	$ 73,295
Restricted cash and cash equivalents	6,261	5,280
Accounts receivable, net	71,988	77,541
Contract assets	20,521	19,481
Income taxes receivable	9,066	765
Prepaid expenses and other current assets	27,574	31,282
Total current assets	210,713	207,644
Equipment and improvements, net	12,030	14,539
Capitalized software costs, net	41,570	41,474
Operating lease assets	14,431	18,446
Deferred income taxes, net	19,445	19,474
Contract assets, net of current	1,991	1,976
Intangibles, net	30,502	36,700
Goodwill	267,212	267,212
Other assets	37,628	37,021
Total assets	635,522	644,486
Current liabilities:
Accounts payable	12,687	11,378
Contract liabilities	53,506	52,863
Accrued compensation and related benefits	34,053	50,374
Income taxes payable	201	584
Operating lease liabilities	11,290	12,735
Other current liabilities	59,440	52,699
Total current liabilities	171,177	180,633
Deferred compensation	7,275	6,620
Operating lease liabilities, net of current	14,646	18,453
Other noncurrent liabilities	7,148	7,136
Total liabilities	200,246	212,842
Commitments and contingencies (Note 15)
Shareholders' equity:
$0.01 par value; authorized 100,000 shares; issued and outstanding 68,394 and 67,069 shares at September 30, 2021 and March 31, 2021, respectively	684	671
Additional paid-in capital	311,793	304,263
Accumulated other comprehensive loss	(1,912)	(1,924)
Retained earnings	124,711	128,634
Total shareholders' equity	435,276	431,644
Total liabilities and shareholders' equity	$ 635,522	$ 644,486

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Sep. 30, 2021	Mar. 31, 2021
Statement Of Financial Position [Abstract]
Common stock, par value (in USD per share)	$ 0.01	$ 0.01
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	68,394,000	67,069,000
Common stock, shares outstanding	68,394,000	67,069,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss) (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Revenues:
Total revenues	$ 149,286	$ 140,002	$ 295,370	$ 270,881
Cost of revenue:
Amortization of capitalized software costs and acquired intangible assets	7,969	9,961	16,053	19,860
Total cost of revenue	72,698	68,950	145,439	135,319
Gross profit	76,588	71,052	149,931	135,562
Operating expenses:
Selling, general and administrative	63,891	41,950	112,377	82,687
Research and development costs, net	18,518	17,692	37,839	35,914
Amortization of acquired intangible assets	881	1,112	1,762	2,224
Impairment of assets	1,195		1,577
Restructuring costs			539	2,562
Total operating expenses	84,485	60,754	154,094	123,387
Income (loss) from operations	(7,897)	10,298	(4,163)	12,175
Interest income	17	12	29	18
Interest expense	(320)	(1,135)	(637)	(2,242)
Other expense, net	(12)	(18)	(34)	(2)
Income (loss) before provision for (benefit of) income taxes	(8,212)	9,157	(4,805)	9,949
Provision for (benefit of) income taxes	(1,441)	(1,298)	(882)	318
Net income (loss)	(6,771)	10,455	(3,923)	9,631
Other comprehensive income:
Foreign currency translation, net of tax	50	102	12	89
Comprehensive income (loss)	$ (6,721)	$ 10,557	$ (3,911)	$ 9,720
Net income (loss) per share:
Basic	$ (0.10)	$ 0.16	$ (0.06)	$ 0.14
Diluted	$ (0.10)	$ 0.16	$ (0.06)	$ 0.14
Weighted-average shares outstanding:
Basic	67,406	66,688	67,291	66,493
Diluted	67,406	66,689	67,291	66,493
Recurring
Revenues:
Total revenues	$ 135,609	$ 125,691	$ 267,990	$ 245,213
Cost of revenue:
Cost of revenue excluding amortization of capitalized software costs and acquired intangible assets	57,119	52,906	114,279	103,335
Software, Hardware, and Other Non-recurring
Revenues:
Total revenues	13,677	14,311	27,380	25,668
Cost of revenue:
Cost of revenue excluding amortization of capitalized software costs and acquired intangible assets	$ 7,610	$ 6,083	$ 15,107	$ 12,124

Condensed Consolidated Statem_2

Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Loss
Balance at Mar. 31, 2020	$ 400,494	$ 661	$ 282,857	$ 119,119	$ (2,143)
Balance, Shares at Mar. 31, 2020		66,134
Common stock issued under stock plans, net of shares withheld for taxes	(1,408)	$ 6	(1,414)
Common stock issued under stock plans, net of shares withheld for taxes, Shares		535
Stock-based compensation	5,393		5,393
Other comprehensive income:
Translation adjustments	(13)				(13)
Net income (loss)	(824)			(824)
Balance at Jun. 30, 2020	403,642	$ 667	286,836	118,295	(2,156)
Balance, Shares at Jun. 30, 2020		66,669
Balance at Mar. 31, 2020	400,494	$ 661	282,857	119,119	(2,143)
Balance, Shares at Mar. 31, 2020		66,134
Other comprehensive income:
Translation adjustments	89
Net income (loss)	9,631
Balance at Sep. 30, 2020	419,591	$ 667	292,228	128,750	(2,054)
Balance, Shares at Sep. 30, 2020		66,734
Balance at Jun. 30, 2020	403,642	$ 667	286,836	118,295	(2,156)
Balance, Shares at Jun. 30, 2020		66,669
Common stock issued under stock plans, net of shares withheld for taxes	(45)		(45)
Common stock issued under stock plans, net of shares withheld for taxes, Shares		65
Stock-based compensation	5,437		5,437
Other comprehensive income:
Translation adjustments	102				102
Net income (loss)	10,455			10,455
Balance at Sep. 30, 2020	419,591	$ 667	292,228	128,750	(2,054)
Balance, Shares at Sep. 30, 2020		66,734
Balance at Mar. 31, 2021	431,644	$ 671	304,263	128,634	(1,924)
Balance, Shares at Mar. 31, 2021		67,069
Common stock issued under stock plans, net of shares withheld for taxes	(2,298)	$ 3	(2,301)
Common stock issued under stock plans, net of shares withheld for taxes, Shares		293
Stock-based compensation	6,412		6,412
Other comprehensive income:
Translation adjustments	(38)				(38)
Net income (loss)	2,848			2,848
Balance at Jun. 30, 2021	438,568	$ 674	308,374	131,482	(1,962)
Balance, Shares at Jun. 30, 2021		67,362
Balance at Mar. 31, 2021	431,644	$ 671	304,263	128,634	(1,924)
Balance, Shares at Mar. 31, 2021		67,069
Other comprehensive income:
Translation adjustments	12
Net income (loss)	(3,923)
Balance at Sep. 30, 2021	435,276	$ 684	311,793	124,711	(1,912)
Balance, Shares at Sep. 30, 2021		68,394
Balance at Jun. 30, 2021	438,568	$ 674	308,374	131,482	(1,962)
Balance, Shares at Jun. 30, 2021		67,362
Common stock issued under stock plans, net of shares withheld for taxes	(1,794)	$ 10	(1,804)
Common stock issued under stock plans, net of shares withheld for taxes, Shares		1,032
Stock-based compensation	5,223		5,223
Other comprehensive income:
Translation adjustments	50				50
Net income (loss)	(6,771)			(6,771)
Balance at Sep. 30, 2021	$ 435,276	$ 684	$ 311,793	$ 124,711	$ (1,912)
Balance, Shares at Sep. 30, 2021		68,394

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash flows from operating activities:
Net income (loss)	$ (3,923)	$ 9,631
Adjustments to reconcile net income to net cash provided by operating activities:
Amortization of capitalized software costs	11,617	9,853
Amortization of debt issuance costs	254	355
Amortization of other intangibles	6,198	12,232
Change in fair value of contingent consideration		50
Deferred income taxes	29	(27)
Depreciation	3,781	3,937
Excess tax deficiency from share-based compensation	640	941
Impairment of assets	1,577
Loss on disposal of equipment and improvements	77
Non-cash operating lease costs	3,087	3,421
Provision for bad debts	679	1,399
Share-based compensation	11,635	10,830
Changes in assets and liabilities:
Accounts receivable	4,874	3,505
Contract assets	(1,055)	(2,481)
Accounts payable	1,108	(3,756)
Contract liabilities	643	(8,344)
Accrued compensation and related benefits	(16,321)	8,348
Income taxes	(9,324)	(2,083)
Deferred compensation	655	840
Operating lease liabilities	(5,360)	(5,224)
Other assets and liabilities	9,608	4,605
Net cash provided by operating activities	20,479	48,032
Cash flows from investing activities:
Additions to capitalized software costs	(11,713)	(12,083)
Additions to equipment and improvements	(1,685)	(764)
Acquisition related working capital adjustment payments		(206)
Net cash used in investing activities	(13,398)	(13,053)
Cash flows from financing activities:
Proceeds from line of credit		50,000
Repayments on line of credit		(115,000)
Proceeds from issuance of shares under employee plans	1,109	798
Payments for taxes related to net share settlement of equity awards	(5,201)	(2,251)
Net cash used in financing activities	(4,092)	(66,453)
Net increase (decrease) in cash, cash equivalents, and restricted cash	2,989	(31,474)
Cash, cash equivalents, and restricted cash at beginning of period	78,575	140,319
Cash, cash equivalents, and restricted cash at end of period	81,564	108,845
Supplemental disclosures of cash flow information:
Cash paid for income taxes	7,827	1,566
Cash refunds from income taxes	19	107
Cash paid for interest	190	1,905
Cash paid for amounts included in the measurement of operating lease liabilities	5,914	6,264
Operating lease assets obtained in exchange for operating lease liabilities	197	3,107
Accrued purchases of equipment and improvements	$ 201	$ 57

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	1. Summary of Significant Accounting Policies Principles of Consolidation. The condensed consolidated financial statements include the accounts of NextGen Healthcare, Inc. and its wholly-owned subsidiaries (collectively, the “Company”). Each of the terms “we,” “us,” or “our” as used herein refers collectively to the Company, unless otherwise stated. All intercompany accounts and transactions have been eliminated. Basis of Presentation. The accompanying unaudited condensed consolidated financial statements as of September 30, 2021 and for the three and six months ended September 30, 2021 have been prepared in accordance with the requirements of Quarterly Report on Form 10-Q and Article 10 of the Securities and Exchange Commission Regulation S-X and therefore do not include all information and notes which would be presented were such condensed consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements presented in our Annual Report on Form 10-K for the fiscal year ended March 31, 2021. In the opinion of management, the accompanying condensed consolidated financial statements reflect all adjustments which are necessary for a fair statement of the results of operations and cash flows for the periods presented. The results of operations for such interim periods are not necessarily indicative of results of operations to be expected for the full year. References to amounts in the condensed consolidated financial statement sections are in thousands, except shares and per share data, unless otherwise specified. Share-Based Compensation. The following table summarizes total share-based compensation expense included in the condensed consolidated statements of net income (loss) and comprehensive income (loss) for the three and six months ended September 30, 2021 and 2020: Three Months Ended September 30, Six Months Ended September 30, 2021 2020 2021 2020 Costs and expenses: Cost of revenue $ 554 $ 589 $ 1,058 $ 1,013 Research and development costs 1,110 1,026 2,153 1,943 Selling, general and administrative 3,559 3,822 8,424 7,874 Total share-based compensation 5,223 5,437 11,635 10,830 Income tax benefit (1,151 ) (1,305 ) (2,733 ) (2,569 ) Decrease in net income $ 4,072 $ 4,132 $ 8,902 $ 8,261 Recently Adopted Accounting Pronouncements. Recently adopted accounting pronouncements are discussed below or in the notes, where applicable. In December 2019, the Financial Accounting Standards Board ("FASB") issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes Recent Accounting Standards Not Yet Adopted. Recent accounting pronouncements requiring implementation in current or future periods are discussed below or in the notes, where applicable. In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting Reference Rate Reform (Topic 848): Scope Topic 848 amended and restated revolving credit agreement Topic 848 e are currently in the process of evaluating the potential impact of adoption of this updated authoritative guidance on our condensed consolidated financial statements We do not believe that any other recently issued, but not yet effective accounting standards, if adopted, would have a material impact on our condensed consolidated financial statements.

Revenue from Contracts with Cus

Revenue from Contracts with Customers	6 Months Ended
	Sep. 30, 2021
Revenue From Contract With Customer [Abstract]
Revenue from Contract with Customer	2. Revenue from Contracts with Customers Revenue Recognition and Performance Obligations We generate revenue from sales of licensing rights and subscriptions to our software solutions, hardware and third-party software products, support and maintenance, managed services, EDI, and other non-recurring services, including implementation, training, and consulting services. Our contracts with customers may include multiple performance obligations that consist of various combinations of our software solutions and related services, which are generally capable of being distinct and accounted for as separate performance obligations. The total transaction price is allocated to each performance obligation within a contract based on estimated standalone selling prices. Revenue is recognized when control of the promised goods or services is transferred to our customers in an amount that reflects the consideration that we expect to be entitled to in exchange for those goods or services. We exclude sales tax from the measurement of the transaction price and The following table presents our revenues disaggregated by our major revenue categories and by occurrence: Three Months Ended September 30, Six Months Ended September 30, 2021 2020 2021 2020 Recurring revenues: Subscription services $ 41,139 $ 36,867 $ 79,423 $ 72,227 Support and maintenance 39,004 38,076 77,490 76,623 Managed services 29,506 26,218 58,937 48,711 Electronic data interchange and data services 25,960 24,530 52,140 47,652 Total recurring revenues 135,609 125,691 267,990 245,213 Software, hardware, and other non-recurring revenues: Software license and hardware 8,068 8,014 15,282 12,754 Other non-recurring services 5,609 6,297 12,098 12,914 Total software, hardware and other non-recurring revenues 13,677 14,311 27,380 25,668 Total revenues $ 149,286 $ 140,002 $ 295,370 $ 270,881 Recurring revenues consists of subscription services, support and maintenance, managed services, and EDI and data services. Software, hardware, and other non-recurring revenues consists of revenue from sales of software license and hardware and certain non-recurring services, such as implementation, training, and consulting performed for clients who use our products. We generally recognize revenue for our most significant performance obligations as follows: Subscription services. Performance obligations involving subscription services, which include annual libraries, are satisfied over time as the customer simultaneously receives and consumes the benefits of the services throughout the contract period. Our subscription services primarily include our software-as-a-service (“SaaS”) based offerings, such as our electronic health records and practice management, mobile, patient portal, and population health management solutions. Our SaaS-based offerings may include multiple goods and services, such as providing access to our technology-based solutions together with our managed cloud hosting services. These offerings are concurrently delivered with the same pattern of transfer to our customers and are accounted for as a single performance obligation because the technology-based solutions and other goods and services included within our overall SaaS-based offerings are each individually not capable of being distinct as the customer receives benefits based on the combined offering. Our annual libraries primarily consist of providing stand-ready access to certain content, knowledgebase, databases, and SaaS-based educational tools, which are frequently updated to meet the most current standards and requirements, to be utilized in conjunction with our core solutions. We recognize revenue related to these subscription services, including annual libraries, ratably over the respective noncancelable contract term. Support and maintenance. Performance obligations involving support and maintenance are satisfied over time as the customer simultaneously receives and consumes the benefits of the maintenance services provided. Our support and maintenance services may consist of separate performance obligations, such as unspecified upgrades or enhancements and technical support, which are considered stand-ready in nature and can be offered at various points during the service period. Since the efforts associated with the combined support and maintenance services are rendered concurrently and provided evenly throughout the service period, we consider the series of support and maintenance services to be a single performance obligation. Therefore, we recognize revenue related to these services ratably over the respective noncancelable contract term. Managed services. Managed services consist primarily of RCM and related services, but also includes our hosting services, which we refer to as managed cloud services, transcription services, patient pay services, and certain other recurring services. Performance obligations associated with RCM services are satisfied over time as the customer simultaneously receives and consumes the benefits of the services executed throughout the contract period. The majority of service fees under our RCM arrangements are variable consideration contingent upon collections by our clients. We estimate the variable consideration which we expect to be entitled to over the noncancelable contract term associated with our RCM service arrangements. The estimate of variable consideration included in the transaction price typically involves estimating the amounts we will ultimately collect on behalf of our clients and the relative fee we charge that is generally calculated as a percentage of those collections. Inputs to these estimates include, but are not limited to, historical service fees and collections amounts, timing of historical collections relative to the timing of when claims are submitted by our clients to their respective payers, macroeconomic trends, and anticipated changes in the number of providers. Significant judgement is required when estimating the total transaction price based on the variable consideration. We may apply certain constraints when appropriate whereby we include in the transaction price estimated variable consideration only to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. Such estimates are assessed at the contract level. RCM and related services may not be rendered evenly over the contract period as the timing of services are based on customer collections, which may vary throughout the service period. We recognize revenue for RCM based on the amount of collections received throughout the contract term as it most closely depicts our efforts to transfer our service obligations to the customer. Our managed cloud services represent a single performance obligation to provide cloud hosting services to our customers and related revenue is recognized ratably over the respective noncancelable contract term. Performance obligations related to the transcription services, patient pay services, and other recurring services are satisfied as the corresponding services are provided and revenue is recognized as such services are rendered. Electronic data interchange and data services. Performance obligations related to EDI and other transaction processing services are satisfied at the point in time the services are rendered. The transfer of control occurs when the transaction processing services are delivered and the customer receives the benefits from the services provided. Software license and hardware. Software license and hardware are considered point-in-time performance obligations as control is transferred to customers upon the delivery of the software license and hardware. Our software licenses are considered functional licenses, and revenue recognition generally occurs on the date of contract execution as the customer is provided with immediate access to the license. We generally determine the amount of consideration allocated to the software license performance obligation using the residual approach, except for certain RCM arrangements where the amount allocated to the software license performance obligation is determined based on estimated relative standalone selling prices. For hardware, we recognize revenue upon transfer of such hardware or devices to the customer. Other non-recurring services. Performance obligations related to other non-recurring services, including implementation, training, and consulting services, are generally satisfied as the corresponding services are provided. Once the services have been provided to the customer, the transfer of control has occurred. Therefore, we recognize revenue as such services are rendered. Transaction Price Allocated to Remaining Performance Obligations As of September 30, 2021, the aggregate amount of transaction price related to remaining unsatisfied or partially unsatisfied performance obligations over the respective noncancelable contract term was approximately $531,800, of which we expect to recognize approximately 10% as services are rendered or goods are delivered , 52 As of September 30, 2020, the aggregate amount of transaction price related to remaining unsatisfied or partially unsatisfied performance obligations over the respective noncancelable contract term was approximately $471,700, of which we expect to recognize approximately 10% as services are rendered or goods are delivered, 53% over the next 12 months, and the remainder thereafter. Contract Balances Contract balances result from the timing differences between our revenue recognition, invoicing, and cash collections. Such contract balances include accounts receivables, contract assets and liabilities, and other customer deposits and liabilities balances. Accounts receivables include invoiced amounts where the right to receive payment is unconditional and only subject to the passage of time. Contract assets, consisting of unbilled receivables, include amounts where revenue recognized exceeds the amount invoiced to the customer and the right to payment is not solely subject to the passage of time. Contract assets are generally associated with our sales of software licenses, but may also be associated with other performance obligations such as subscription services, support and maintenance, annual libraries, and professional services, where control has been transferred to our customers but the associated payments are based on future customer collections (in the case of our RCM service arrangements) or based on future milestone payment due dates. In such instances, the revenue recognized may exceed the amount invoiced to the customer and such balances are included in contract assets since our right to receive payment is not unconditional, but rather is conditional upon customer collections or the continued functionality of the software and our ongoing support and maintenance obligations. Contract liabilities consist mainly of fees invoiced or paid by our clients for which the associated services have not been performed and revenues have not been recognized. Contract assets and contract liabilities are reported in a net position on an individual contract basis at the end of each reporting period. Contract assets are classified as current or long-term on our condensed consolidated balance sheets based on the timing of when we expect to complete the related performance obligations and invoice the customer. Contract liabilities are classified as current on our condensed consolidated balance sheets since the revenue recognition associated with the related customer payments and invoicing is expected to occur within the next twelve months. During the three months ended September 30, 2021 and 2020, we recognized $17,607 and $19,319, respectively, of revenues that were included in the contract liability balance or invoiced to customers since the beginning of the corresponding periods. During the six months ended September 30, 2021 and 2020, we recognized $35,388 and $40,145, respectively, of revenues that were included in the contract liability balance or invoiced to customers since the beginning of the corresponding periods. Our contracts with customers do not include any major financing components. Costs to Obtain or Fulfill a Contract We capitalize all incremental costs of obtaining a contract with a customer to the extent that such costs are directly related to a contract and expected to be recoverable. Our sales commissions and related sales incentives are considered incremental costs requiring capitalization. Capitalized contract costs are amortized to expense utilizing a method that is consistent with the transfer of the related goods or services to the customer. The amortization period ranges from less than one year up to five years, based on the period over which the related goods and services are transferred, including consideration of the expected customer renewals and the related useful lives of the products. Capitalized commissions costs were $30,437 as of September 30, 2021 three months ended September 30, 2021 and 2020 six months ended September 30, 2021 and 2020 consolidated statements of net income (loss) and comprehensive income (loss).

Accounts Receivable

Accounts Receivable	6 Months Ended
	Sep. 30, 2021
Receivables [Abstract]
Accounts Receivable	3. Accounts Receivable Accounts receivable includes invoiced amounts where the right to receive payment is unconditional and only subject to the passage of time. Allowance for doubtful accounts are reported as a component of accounts receivable as summarized below: September 30, 2021 March 31, 2021 Accounts receivable, gross $ 75,641 $ 81,746 Allowance for doubtful accounts (3,653 ) (4,205 ) Accounts receivable, net $ 71,988 $ 77,541 The following table represents the changes in the allowance for doubtful accounts, as of and for the three months ended September 30, 2021: Balance as of June 30, 2021 $ (4,099 ) Additions charged to costs and expenses (40 ) Deductions 486 Balance as of September 30, 2021 $ (3,653 ) The following table represents the changes in the allowance for doubtful accounts, as of and for the six months ended September 30, 2021: Balance as of March 31, 2021 $ (4,205 ) Additions charged to costs and expenses (679 ) Deductions 1,231 Balance as of September 30, 2021 $ (3,653 )

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Sep. 30, 2021
Fair Value Disclosures [Abstract]
Fair Value Measurements	4. Fair Value Measurements The following tables set forth by level within the fair value hierarchy our financial assets and liabilities that were accounted for at fair value on a recurring basis at September 30, 2021 and March 31, 2021: Balance At Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Unobservable Inputs September 30, 2021 (Level 1) (Level 2) (Level 3) ASSETS Cash and cash equivalents (1) $ 75,303 $ 75,303 $ — $ — Restricted cash and cash equivalents 6,261 6,261 — — $ 81,564 $ 81,564 $ — $ — LIABILITIES Contingent consideration related to acquisitions $ 533 $ — $ 533 $ — $ 533 $ — $ 533 $ — Balance At Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Unobservable Inputs March 31, 2021 (Level 1) (Level 2) (Level 3) ASSETS Cash and cash equivalents (1) $ 73,295 $ 73,295 $ — $ — Restricted cash and cash equivalents 5,280 5,280 — — $ 78,575 $ 78,575 $ — $ — LIABILITIES Contingent consideration related to acquisitions $ 533 $ — $ 533 $ — $ 533 $ — $ 533 $ — (1) Cash equivalents consist primarily of money market funds. We believe that the fair value of our other financial assets and liabilities, including accounts receivable, accounts payable, and line of credit, approximate their respective carrying values due to their nominal credit risk. As of September 30, 2021 and March 31, 2021, the contingent consideration liability balance of $533 relates to the acquisition of Topaz Information Systems, LLC, for which we may pay up to an additional $2,000 of cash contingent consideration in the form of an earnout, subject to the achievement of certain operational targets through April 2021. The fair value of the contingent consideration liability was calculated based on actual earnout achievement through the end of the performance period. Non-Recurring Fair Value Measurements We have certain assets, including goodwill and other intangible assets, which are measured at fair value on a non-recurring basis and are adjusted to fair value only if an impairment charge is recognized. The categorization of the framework used to measure fair value of the assets is considered to be within the Level 3 valuation hierarchy due to the subjective nature of the unobservable inputs used.

Leases

Leases	6 Months Ended
	Sep. 30, 2021
Leases [Abstract]
Leases	5. Leases Our leasing arrangements are reflected on the balance sheet as right-of-use assets and liabilities pertaining to the rights and obligations created by the leased assets. Right-of-use lease assets and corresponding lease liabilities are recognized at commencement date based on the present value of lease payments over the expected lease term. Since the interest rate implicit in our lease arrangements is not readily determinable, we determine an incremental borrowing rate for each lease based on the approximate interest rate on a collateralized basis with similar remaining terms and payments as of the lease commencement date to determine the present value of future lease payments. Our lease terms may include options to extend or terminate the lease. Currently, it is not reasonably certain that we will exercise those options and therefore, we utilize the initial , non cancelable , lease term to calculate the lease assets and corresponding liabilities for all our leases. We have certain insignificant short-term leases with an initial term of twelve months or less that are not recorded in our condensed consolidated balance sheets. Operating right-of-use lease assets are classified as operating lease assets on our condensed consolidated balance sheets. We determine whether an arrangement is a lease at inception and classify it as finance or operating. All of our existing material leases are classified as operating leases. Our leases do not contain any residual value guarantees. Our lease agreements generally contain lease and non-lease components. Non-lease components primarily include payments for maintenance and utilities. We have applied the practical expedient to combine fixed payments for non-lease components with our lease payments for all of our leases and account for them together as a single lease component, which increases the amount of our lease assets and corresponding liabilities. Payments under our lease arrangements are primarily fixed, however, certain lease agreements contain variable payments, which are expensed as incurred and not included in the operating lease assets and liabilities. Operating lease costs are recognized on a straight-line basis over the lease term and included as a selling, general and administrative expense in the condensed consolidated statements of net income (loss) and comprehensive income Components of operating lease costs are summarized as follows: Three Months Ended September 30, Six Months Ended September 30, 2021 2020 2021 2020 Operating lease costs $ 1,602 $ 2,093 $ 3,435 $ 4,184 Short-term lease costs 2 6 8 13 Variable lease costs 204 289 361 586 Less: Sublease income (123 ) (123 ) (255 ) (248 ) Total operating lease costs $ 1,685 $ 2,265 $ 3,549 $ 4,535 Supplemental cash flow information related to operating leases is summarized as follows: Three Months Ended September 30, Six Months Ended September 30, 2021 2020 2021 2020 Cash paid for amounts included in the measurement of operating lease liabilities $ 2,950 $ 3,132 $ 5,914 $ 6,264 Operating lease assets obtained in exchange for operating lease liabilities 197 3,107 197 3,107 We have operating lease agreements for our offices in the United States and India with lease periods expiring between 2022 For the year ended March 31, 2022 (remaining six months) $ 7,853 2023 8,283 2024 6,337 2025 3,824 2026 1,257 Total future lease payments 27,554 Less interest (1,618 ) Total lease liabilities $ 25,936 In the three and six months ended September 30, 2021, we vacated portions of certain leased locations and recorded impairments of $1,195 and $1,577, respectively, to our right-of-use assets and certain related fixed assets associated with the vacated locations, or portions thereof, in Irvine, CA and Fairport, NY based on projected sublease rental income and estimated sublease commencement dates. The impairment analysis was performed at the asset group level and the impairment charge was estimated by comparing the fair value of each asset group based on the expected cash flows to its respective book value. We determined the discount rate for each asset group based on the approximate interest rate on a collateralized basis with similar remaining terms and payments as of the impairment date. Significant judgment was required to estimate the fair value of each asset group and actual results could vary from the estimates, resulting in potential future adjustments to amounts previously recorded.

Goodwill

Goodwill	6 Months Ended
	Sep. 30, 2021
Goodwill And Intangible Assets Disclosure [Abstract]
Goodwill	6. Goodwill We test goodwill for impairment annually during our first fiscal quarter, referred to as the annual test date. We will also test for impairment between annual test dates if an event occurs or circumstances change that would indicate the carrying amount may be impaired. Impairment testing for goodwill is performed at a reporting-unit level, which is defined as an operating segment or one level below an operating segment (referred to as a component). We operate as one segment and have a single reporting unit. The measures evaluated by our chief operating decision maker ("CODM"), consisting of the Chief Executive Officer, to assess company performance and make decisions about the allocation of resources include consolidated revenue and consolidated operating results. We have not identified any events or circumstances as of September 30, 2021 that would require an interim goodwill impairment test. We do not amortize goodwill as it has been determined to have an indefinite useful life. The carrying amount of goodwill as of September 30, 2021 and March 31, 2021 was $267,212.

Intangible Assets

Intangible Assets	6 Months Ended
	Sep. 30, 2021
Goodwill And Intangible Assets Disclosure [Abstract]
Intangible Assets	7. Intangible Assets Our definite-lived intangible assets, other than capitalized software development costs, are summarized as follows: September 30, 2021 Customer Relationships Trade Names Software Technology Total Gross carrying amount $ 39,200 $ 250 $ 49,000 $ 88,450 Accumulated amortization (28,086 ) (92 ) (29,770 ) (57,948 ) Net intangible assets $ 11,114 $ 158 $ 19,230 $ 30,502 March 31, 2021 Customer Relationships Trade Names Software Technology Total Gross carrying amount $ 39,200 $ 250 $ 91,500 $ 130,950 Accumulated amortization (26,349 ) (67 ) (67,834 ) (94,250 ) Net intangible assets $ 12,851 $ 183 $ 23,666 $ 36,700 Amortization expense related to customer relationships and trade names recorded as operating expenses in the condensed consolidated statements of net income (loss) and comprehensive income (loss) was $881 and $1,112 for the three months ended September 30, 2021 and 2020, respectively. Amortization expense related to software technology recorded as cost of revenue was $2,218 and $4,872 for the three months ended September 30, 2021 and 2020, respectively. Amortization expense related to customer relationships and trade names recorded as operating expenses in the condensed consolidated statements of net income (loss) and comprehensive income (loss) was $1,762 and $2,224 for the six months ended September 30, 2021 and 2020, respectively. Amortization expense related to software technology recorded as cost of revenue was $4,436 and $10,008 for the six months ended September 30, 2021 and 2020, respectively. The following table summarizes the remaining estimated amortization of definite-lived intangible assets as of September 30, 2021: Estimated Remaining Amortization Expense Operating Expense Cost of Revenue Total For the year ended March 31, 2022 (remaining six months) $ 1,762 $ 4,436 $ 6,198 2023 2,820 5,154 7,974 2024 2,279 3,573 5,852 2025 1,846 3,573 5,419 2026 1,377 2,251 3,628 2027 and beyond 1,188 243 1,431 Total $ 11,272 $ 19,230 $ 30,502

Capitalized Software Costs

Capitalized Software Costs	6 Months Ended
	Sep. 30, 2021
Research And Development [Abstract]
Capitalized Software Costs	8. Capitalized Software Costs Our capitalized software costs are summarized as follows: September 30, 2021 March 31, 2021 Gross carrying amount $ 106,810 $ 96,908 Accumulated amortization (65,240 ) (55,434 ) Net capitalized software costs $ 41,570 $ 41,474 Amortization expense related to capitalized software costs was $5,751 and $5,090 for the three months ended September 30, 2021 and 2020, respectively, and is recorded as cost of revenue in the condensed consolidated statements of net income (loss) and comprehensive income (loss). Amortization expense related to capitalized software costs was $11,617 and $9,853 for the six months ended September 30, 2021 and 2020, respectively. The following table presents the remaining estimated amortization of capitalized software costs as of September 30, 2021. The estimated amortization is comprised of (i) amortization of released products and (ii) the expected amortization for products that are not yet available for sale based on their estimated economic lives and projected general release dates. For the year ended March 31, 2022 (remaining six months) $ 14,000 2023 17,400 2024 7,800 2025 2,200 2026 170 Total $ 41,570

Line of Credit

Line of Credit	6 Months Ended
	Sep. 30, 2021
Debt Disclosure [Abstract]
Line of Credit	9. Line of Credit On March 12, 2021, we entered into a $300,000 second amended and restated revolving credit agreement (the “Credit Agreement”) with JPMorgan Chase Bank, N.A., as administrative agent (in such capacity, the “Administrative Agent”), U.S. Bank National Association and Bank of the West, as co-syndication agents, and certain other agents and lenders. The Credit Agreement replaces our prior $300,000 amended and restated revolving credit agreement, originally entered into on January 4, 2016 and amended on March 29, 2018 (“Original Credit Agreement”). The Credit Agreement provides a subfacility of up to $10,000 for letters of credit and a subfacility of up to $10,000 for swing-line loans. The Credit Agreement also provides us with the ability to obtain up to $150,000 in the aggregate of additional revolving credit commitments and/or term loans thereunder (i.e., in excess of $300,000) upon satisfaction of certain conditions, including receipt of commitments from new or existing lenders to provide such additional revolving credit commitments and/or term loans. The Credit Agreement matures on March 12, 2026 and the full balance of the revolving loans and all other obligations under the Credit Agreement must be paid at that time. In addition, we are required to prepay the revolving loan balance if at any time the aggregate principal amount outstanding under the Credit Agreement exceeds the aggregate commitments thereunder. The Credit Agreement is secured by substantially all of our existing and future property and our material domestic subsidiaries. The revolving loans under the Credit Agreement will be available for letters of credit, permitted acquisitions, working capital and general corporate purposes. We were in compliance with all financial and non-financial covenants under the Credit Agreement as of September 30, 2021. As of September 30, 2021 and March 31, 2021, we had no outstanding loans and $300,000 of unused credit under the Credit Agreement. Interest expense related to the Credit Agreement was $193 and $928 for the three months ended September 30, 2021 and 2020, respectively. Amortization of deferred debt issuance costs was $127 and $178 for the three months ended September 30, 2021 and 2020, respectively. Interest expense related to the Credit Agreement was $383 and $1,856 for the six months ended September 30, 2021 and 2020, respectively. Amortization of deferred debt issuance costs was $254 and $355 for the six months ended September 30, 2021 and 2020, respectively.

Composition of Certain Financia

Composition of Certain Financial Statement Captions	6 Months Ended
	Sep. 30, 2021
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Composition of Certain Financial Statement Captions	10. Composition of Certain Financial Statement Captions Cash, cash equivalents, and restricted cash are summarized as follows: September 30, 2021 March 31, 2021 Cash and cash equivalents $ 75,303 $ 73,295 Restricted cash and cash equivalents 6,261 5,280 Cash, cash equivalents, and restricted cash $ 81,564 $ 78,575 Prepaid expenses and other current assets are summarized as follows: September 30, 2021 March 31, 2021 Prepaid expenses $ 15,969 $ 20,679 Capitalized commissions costs 10,880 9,399 Other current assets 725 1,204 Prepaid expenses and other current assets $ 27,574 $ 31,282 Equipment and improvements are summarized as follows: September 30, 2021 March 31, 2021 Computer equipment $ 35,977 $ 35,244 Internal-use software 18,828 18,174 Furniture and fixtures 10,720 11,555 Leasehold improvements 14,406 14,418 Equipment and improvements, gross 79,931 79,391 Accumulated depreciation and amortization (67,901 ) (64,852 ) Equipment and improvements, net $ 12,030 $ 14,539 Other assets are summarized as follows: September 30, 2021 March 31, 2021 Capitalized commission costs $ 19,557 $ 19,104 Deposits 5,896 5,505 Debt issuance costs 2,260 2,521 Other noncurrent assets 9,915 9,891 Other assets $ 37,628 $ 37,021 Accrued compensation and related benefits are summarized as follows: September 30, 2021 March 31, 2021 Accrued bonus $ 14,377 $ 29,382 Accrued vacation 11,667 12,038 Accrued commissions 3,655 4,628 Deferred payroll taxes 3,817 3,817 Accrued payroll and other 537 509 Accrued compensation and related benefits $ 34,053 $ 50,374 Other current and noncurrent liabilities are summarized as follows: September 30, 2021 March 31, 2021 Accrued legal expense $ 8,501 $ 6,302 Accrued hosting costs 8,228 6,158 Care services liabilities 6,261 5,280 Sales returns reserves and other customer liabilities 6,016 9,449 Accrued proxy contest expense 5,873 — Customer credit balances and deposits 4,917 4,638 Accrued consulting and outside services 3,972 3,002 Accrued employee benefits and withholdings 3,518 4,649 Accrued self insurance expense 2,468 1,737 Accrued outsourcing costs 2,234 2,266 Accrued EDI expense 1,927 2,020 Accrued royalties 829 3,125 Accrued taxes payable 640 586 Contingent consideration related to acquisitions 533 533 Other accrued expenses 3,523 2,954 Other current liabilities $ 59,440 $ 52,699 Deferred payroll taxes $ 3,817 3,817 Uncertain tax positions 3,175 3,175 Other liabilities 156 144 Other noncurrent liabilities $ 7,148 $ 7,136

Income Taxes

Income Taxes	6 Months Ended
	Sep. 30, 2021
Income Tax Disclosure [Abstract]
Income Taxes	11. Income Taxes The benefit of income taxes in the three months ended September 30, 2021 and 2020 was $1,441 and $1,298, respectively, reflecting an effective tax rate of 17.5% and an effective tax rate benefit of 14.2%, respectively. The benefit of income taxes in the six months ended September 30, 2021 was $882, reflecting an effective tax rate benefit of 18.4%. The provision for income taxes in the six months ended September 30, 2020 was $318, reflecting an effective tax rate of 3.2%. The increases in the effective tax rates for the three and six months ended September 30, 2021 compared to the prior period was primarily due to a net decrease of the research and development credit, foreign rate differential benefit, and higher nondeductible officer compensation. The deferred tax assets and liabilities are presented net in the accompanying condensed consolidated balance sheets as noncurrent. We expect to receive the full benefit of the deferred tax assets recorded, with the exception of certain state credits and state net operating loss carryforwards, for which we have recorded a valuation allowance. We had unrecognized tax benefits of $4,438 and $4,426 related to various federal, state, and local income tax matters as of September 30, 2021 and March 31, 2021, respectively. The unrecognized benefits consisted of liabilities of $3,164 and $3,175 and reserves as of September 30, 2021 and March 31, 2021, respectively, against deferred tax assets of $1,274 and $1,251 as of September 30, 2021 and March 31, 2021, respectively. If recognized, this amount would reduce our effective tax rate. We are no longer subject to United States federal income tax examinations for tax years before fiscal year ended 2017. With a few exceptions, we are no longer subject to state or local income tax examinations for tax years before fiscal year ended 2016. We do not anticipate the total unrecognized tax benefits to significantly change due to the settlement of audits or the expiration of statute of limitations within the next twelve months.

Earnings Per Share

Earnings Per Share	6 Months Ended
	Sep. 30, 2021
Earnings Per Share [Abstract]
Earnings Per Share	12. Earnings per Share The dual presentation of “basic” and “diluted” earnings per share is provided below. Share amounts below are in thousands. Three Months Ended September 30, Six Months Ended September 30, 2021 2020 2021 2020 Earnings per share — Basic: Net income (loss) $ (6,771 ) $ 10,455 $ (3,923 ) $ 9,631 Weighted-average shares outstanding — Basic 67,406 66,688 67,291 66,493 Net income (loss) per common share — Basic $ (0.10 ) $ 0.16 $ (0.06 ) $ 0.14 Earnings per share — Diluted: Net income (loss) $ (6,771 ) $ 10,455 $ (3,923 ) $ 9,631 Weighted-average shares outstanding 67,406 66,688 67,291 66,493 Effect of potentially dilutive securities — 1 — — Weighted-average shares outstanding — Diluted 67,406 66,689 67,291 66,493 Net income (loss) per common share — Diluted $ (0.10 ) $ 0.16 $ (0.06 ) $ 0.14 The computation of diluted net income (loss) per share does not include 697 and 2,787 options to acquire shares of common stock for the three months ended September 30, 2021 and September 30, 2020, respectively, because their inclusion would have an anti-dilutive effect on net income (loss) per share. The computation of diluted net income (loss) per share does not include 254 and 2,954 options to acquire shares of common stock for the six months ended September 30, 2021 and September 30, 2020, respectively, because their inclusion would have an anti-dilutive effect on net income (loss) per share.

Share-Based Awards

Share-Based Awards	6 Months Ended
	Sep. 30, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Share-Based Awards	13. Share-Based Awards Equity Incentive Plans In October 2005, our shareholders approved a stock option and incentive plan (the “2005 Plan”) under which 4,800,000 shares of common stock were reserved for the issuance of awards, including incentive stock options and non-qualified stock options, stock appreciation rights, restricted stock, unrestricted stock, restricted stock units, performance shares, performance units (including performance options) and other share-based awards. The 2005 Plan provides that our employees and directors may, at the discretion of the Board of Directors ("Board") or a duly designated compensation committee, be granted certain share-based awards. In the case of option awards granted under the 2005 Plan, the exercise price of each option is determined based on the date of grant and expire no later than 10 years from the date of grant. Awards granted pursuant to the 2005 Plan are subject to the vesting schedule or performance metrics set forth in the agreements pursuant to which they are granted. Upon a change of control of our Company, as such term is defined in the 2005 Plan, awards under the 2005 Plan will fully vest under certain circumstances. The 2005 Plan expired on May 25, 2015. As of September 30, 2021, there were 84,200 outstanding options under the 2005 Plan. In August 2015, our shareholders approved a stock option and incentive plan (the “2015 Plan”) under which 11,500,000 shares of common stock were reserved for the issuance of awards, including incentive stock options and non-qualified stock options, stock appreciation rights, restricted stock awards and restricted stock unit awards, performance stock awards and other share-based awards. In August 2017, our shareholders approved an amendment to the 2015 Plan, (the “Amended 2015 Plan”), to, among other items, increase the number of shares of common stock reserved for issuance thereunder by 6,000,000, which was further amended in August 2019 as approved by our shareholders, to, among other items, increase the number of shares of common stock reserved for issuance thereunder by an additional 3,575,000. The Amended 2015 Plan provides that our employees and directors may, at the discretion of the Board or a duly designated compensation committee, be granted certain share-based awards. In the case of option awards granted under the Amended 2015 Plan, the exercise price of each option is determined based on the date of grant and expire no later than 10 years from the date of grant. Awards granted pursuant to the Amended 2015 Plan are subject to the vesting schedule or performance metrics set forth in the agreements pursuant to which they are granted. Upon a change of control of our Company, as such term is defined in the Amended 2015 Plan, awards under the Amended 2015 Plan will fully vest under certain circumstances. As of September 30, 2021, there were 1,618,864 outstanding options, 1,815,406 outstanding shares of restricted stock awards, certain outstanding performance stock unit awards as described further below, and 1,506,567 shares available for future grant under the Amended 2015 Plan. In September 2021, the Board adopted the 2021 Employment Inducement Equity Incentive Plan (the “Inducement Plan”) and initially reserved 1,500,000 shares of common stock for issuance under the Inducement Plan. The Inducement Plan was adopted by the Board without stockholder approval pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules. In accordance with Rule 5635(c)(4) of the Nasdaq Listing Rules, awards under the Inducement Plan may only be made to an employee who has not previously been an employee or member of the Board or the board of directors or any parent or subsidiary, or following a bona fide period of non-employment by the Company or a parent or subsidiary, if he or she is granted such award in connection with his or her commencement of employment with the Company or a subsidiary and such grant is an inducement material to his or her entering into employment with the Company or such subsidiary. The terms of the Inducement Plan are substantially similar to the terms of our Amended 2015 Plan, with the exception that incentive stock options may not be granted under the Inducement Plan. As of September 30, 2021, there were 1,037,614 outstanding shares of restricted stock awards, 450,000 outstanding performance stock unit awards, and 12,386 shares available for future grant under the Inducement Plan. Stock Options The following table summarizes the stock option transactions during the six months ended September 30, 2021: Weighted- Weighted- Average Average Aggregate Exercise Remaining Intrinsic Number of Price Contractual Value Shares per Share Life (years) (in thousands) Outstanding, March 31, 2021 2,791,084 $ 14.47 3.7 $ 10,303 Exercised (1,010,700 ) 13.41 3.2 1,618 Forfeited/Canceled (20,820 ) 21.08 4.7 Expired (56,500 ) 18.85 Outstanding, September 30, 2021 1,703,064 $ 14.88 3.4 $ 309 Vested and expected to vest, September 30, 2021 1,671,176 $ 14.87 3.4 $ 309 Exercisable, September 30, 2021 1,502,682 $ 14.85 3.2 $ 307 Share-based compensation expense related to stock options was $290 and $627 for the three months ended September 30, 2021 and 2020, respectively. Share-based compensation expense related to stock options was $999 and $1,359 for the six months ended September 30, 2021 and 2020, respectively. Non-vested stock option award activity during the six months ended September 30, 2021 is summarized as follows: Weighted- Average Grant-Date Number of Fair Value Shares per Share Outstanding, March 31, 2021 459,339 $ 5.96 Vested (248,957 ) 5.87 Forfeited/Canceled (10,000 ) 8.74 Outstanding, September 30, 2021 200,382 $ 5.94 As of September 30, 2021, $386 of total unrecognized compensation costs related to stock options is expected to be recognized over a weighted-average period of 0.3 years. This amount does not include the cost of new options that may be granted in future periods or any changes in our forfeiture percentage. The total fair value of options vested during the six months ended September 30, 2021 and 2020 was $1,461 and $1,771, respectively. Restricted Stock Awards Restricted stock awards activity during the six months ended September 30, 2021 is summarized as follows: Weighted- Average Grant-Date Number of Fair Value Shares per Share Outstanding, March 31, 2021 2,263,569 $ 14.58 Granted 1,605,649 15.46 Vested (871,842 ) 14.98 Canceled (144,356 ) 14.74 Outstanding, September 30, 2021 2,853,020 $ 14.95 Share-based compensation expense related to restricted stock awards was $3,889 and $4,150 for the three months ended September 30, 2021 and 2020, respectively. Share-based compensation expense related to restricted stock awards was $10,347 and $8,189 for the six months ended September 30, 2021 and 2020, respectively. The weighted-average grant date fair value for the restricted stock awards was estimated using the market price of the common stock on the date of grant. The fair value of the restricted stock awards is amortized on a straight-line basis over the vesting period, which is generally between one to three years. As of September 30, 2021, $35,632 of total unrecognized compensation costs related to restricted stock awards is expected to be recognized over a weighted-average period of 2.3 years. This amount does not include the cost of new restricted stock awards that may be granted in future periods. Performance Stock Units and Awards On October 23, 2018, the Compensation Committee of the Board approved 248,140 performance stock unit awards to be granted to certain executives and non-executive members of the executive leadership team, which vest only in the event certain performance goals are achieved and with continuous service through the date the goals are certified. Approximately 34% of the performance stock units are tied to our cumulative 3-year total shareholder return, 33% are tied to our fiscal year 2021 revenue, and 33% are tied to our fiscal year 2021 adjusted earnings per share goals, each as specifically defined in the equity award agreements. The number of shares to be issued may vary between 50% and 200% of the number of performance stock units depending on performance, and no such shares will be issued if threshold performance is not achieved. The weighted-average grant date fair value of the awards was $17.84 per share, which was estimated using a Monte Carlo-based valuation model for the awards based on total shareholder return and using a probability-adjusted achievement rate combined with the market price of the common stock on the date of grant for the awards based on revenue and earnings per share targets. Share-based compensation expense related to the performance stock unit awards tied to the revenue and adjusted earnings per share goals was not significant. Share-based compensation expense related to the performance stock unit awards tied to total shareholder return was $63 and $114 for the three months ended September 30, 2021 and 2020, respectively. Share-based compensation expense related to the performance stock unit awards was a benefit of $375 for the six months ended September 30, 2021 primarily due to cancellation of awards associated with the departure of our former Chief Executive Officer. Share-based compensation expense related to the performance stock unit awards tied to total shareholder return was $229 for the six months ended September 30, 2020. On December 26, 2019 and January 27, 2020, the Compensation Committee of the Board approved a total of 279,587 performance stock unit awards to be granted to certain executives and non-executive members of the executive leadership team, which vest only in the event certain performance goals are achieved and with continuous service through the date the goals are certified. Approximately 80% of the performance stock units are tied to the Company’s fiscal year 2021 revenue goal and 20% are tied to the Company’s fiscal year 2022 revenue goal. Performance stock unit awards funded for fiscal year 2021 and fiscal year 2022 revenue performance will be modified for cumulative 3-year total shareholder return (“TSR”) on the three-year Share-based compensation expense related to the performance stock unit awards was $226 and $344 for the three months ended September 30, 2 021 and 2020, respectively. Share-based compensation expense related to the performance stock unit awards was a benefit of $231 for the six months ended September 30, 2021 primarily due to cancellation of awards associated with the resignation of our former Chief Executive Officer. Share-based compensation expense related to the performance stock unit awards was $625 for the six months ended September 30, 2020. On October 26, 2020, the Compensation Committee of the Board approved 408,861 performance stock unit awards to be granted to certain executives and non-executive members of the executive leadership team, which vest only in the event certain performance goals are achieved and with continuous service through the date the goals are certified. Approximately 80% of the performance stock units are tied to the Company’s fiscal year 2022 revenue goal and 20% are tied to the Company’s fiscal year 2023 revenue goal. Performance stock unit awards funded for fiscal year 2022 and fiscal year 2023 revenue performance will be modified for cumulative 3-year TSR on the three-year which was estimated using a Monte Carlo-based valuation model for the awards based on total shareholder return and using a probability adjusted achievement rate combined with the market price of the common stock on the date of grant for the awards based on revenue targets. Share-based compensation expense related to the perform On September 20, 2021, the Compensation Committee of the Board approved an award of 450,000 performance stock units to be granted to our Chief Executive Officer. The award has a grant date of September 22, 2021 and portions of the award vest upon both the attainment of five separate pre-determined stock price milestones during a five-year As of September 30, 2 021 , $9,577 of total estimated unrecognized compensation costs related to performance stock units and awards is expected to be recognized over a weighted-average period of 2.4 years. This amount does not include the cost of new performance stock units and awards that may be granted in future periods. Employee Share Purchase Plan On August 11, 2014, our shareholders approved an Employee Share Purchase Plan (the “Purchase Plan”) under which 4,000,000 shares of common stock were reserved for future grant. The Purchase Plan allows eligible employees to purchase shares through payroll deductions of up to 15% of total base salary at a price equal to 90% of the lower of the fair market values of the shares as of the beginning or the end of the corresponding offering period. Any shares purchased under the Purchase Plan are subject to a six-month holding period. Employees are limited to purchasing no more than 1,500 shares on any single purchase date and no more than $25 in total fair market value of shares during any one calendar year. As of September 30, 2 021 Share-based compensation expense recorded for the employee share purchase plan was $129 and $140 for the three months ended September 30, 2 021 September 30, 2 021

Concentration of Credit Risk

Concentration of Credit Risk	6 Months Ended
	Sep. 30, 2021
Risks And Uncertainties [Abstract]
Concentration of Credit Risk	14. Concentration of Credit Risk We had cash deposits at United States banks and financial institutions which exceeded federally insured limits at September 30, 2021. We are exposed to credit loss for amounts in excess of insured limits in the event of non-performance by the institutions; however, we do not anticipate non-performance by these institutions.

Commitments, Guarantees and Con

Commitments, Guarantees and Contingencies	6 Months Ended
	Sep. 30, 2021
Commitments And Contingencies Disclosure [Abstract]
Commitments, Guarantees and Contingencies	15. Commitments, Guarantees and Contingencies Commitments and Guarantees Our software license agreements include a performance guarantee that our software products will substantially operate as described in the applicable program documentation for a period of 365 days after delivery. To date, we have not incurred any significant costs associated with our performance guarantee or other related warranties and do not expect to incur significant warranty costs in the future. Therefore, no accrual has been made for potential costs associated with these warranties. Certain arrangements also include performance guarantees related to response time, availability for operational use, and other performance-related guarantees. Certain arrangements also include penalties in the form of maintenance credits should the performance of the software fail to meet the performance guarantees. To date, we have not incurred any significant costs associated with these warranties and do not expect to incur significant warranty costs in the future. Therefore, no accrual has been made for potential costs associated with these warranties. We historically have accepted sales returns under limited circumstances. We estimate expected sales returns and other forms of variable consideration considering our customary business practice and contract-specific facts and circumstances, and we consider such estimated potential returns as variable consideration when allocating the transaction price to the extent it is probable that there will not be a significant reversal of cumulative revenue recognized. Our standard sales agreements contain an indemnification provision pursuant to which we shall indemnify, hold harmless, and reimburse the indemnified party for losses suffered or incurred by the indemnified party in connection with any United States patent, any copyright or other intellectual property infringement claim by any third-party with respect to our software. As we have not incurred any significant costs to defend lawsuits or settle claims related to these indemnification agreements, we believe that our estimated exposure on these agreements is currently minimal. Accordingly, we have no liabilities recorded for these indemnification obligations . Hussein Litigation On October 7, 2013, a complaint was filed against our Company and certain of our officers and directors in the Superior Court of the State of California for the County of Orange, captioned Ahmed D. Hussein v. Sheldon Razin, Steven Plochocki, Quality Systems, Inc. and Does 1-10, inclusive, No. 30-2013-00679600-CU-NP-CJC, by Ahmed Hussein, a former director and significant shareholder of our Company. After the court sustained our demurrer to the initial complaint, Hussein filed an amended complaint on April 25, 2014. The amended complaint generally alleges fraud and deceit, constructive fraud, negligent misrepresentation and breach of fiduciary duty in connection with statements made to our shareholders regarding our financial condition and projected future performance. The amended complaint seeks actual damages, exemplary and punitive damages and costs. Hussein’s breach of fiduciary duty claims were dismissed on demurrer, and we filed an answer and cross-complaint against Hussein, alleging that he breached fiduciary duties owed to the Company. On September 16, 2015, the Court granted summary judgment with respect to Hussein’s remaining claims, dismissing all claims against us. The cross-complaint against Hussein went to trial, but the Court granted judgment in favor of Hussein on our cross-complaint. Final judgment over Hussein’s claims and our cross-claims was entered on January 9, 2018. Hussein appealed the order granting summary judgment over his claims, and we appealed the court’s decision granting Hussein’s motion for judgment on our cross-complaint. On October 8, 2019, the California State Court of Appeal for the Fourth Appellate District, Division Three, reversed the Superior Court’s grant of summary judgment on Hussein’s affirmative claims and affirmed the trial court’s judgement on the Company’s breach of fiduciary duty claims against Hussein. As a result, the case has returned to the trial court for resolution of Hussein’s claims against us. Trial commenced on July 6, 2021. On July 29, 2021, the jury rendered a verdict in favor of the Company and the individual defendants on all counts. Hussein has filed a Motion for New Trial, which the Court has not yet addressed. Separately, Hussein has issued an arbitration demand seeking indemnification for the fees he incurred defending against our cross-complaint. Following briefing and a hearing at the liability phase of the arbitration, the arbitrator held that Hussein is entitled to indemnification for “expenses” (as that term is defined in Hussein’s indemnification agreement with NextGen) incurred in defense of NextGen’s cross-complaint against him. The arbitrator reserved all other claims related to costs and damages for a second phase of the arbitration. On June 10, 2021, the arbitrator heard arguments on the quantum of indemnifiable expenses. On September 2, 2021, the arbitrator awarded Hussein indemnification for fees and costs incurred defending the cross-complaint. After trebling the fees incurred pursuant to Hussein’s supplemental agreement with his attorneys, and adding in interest and costs, the arbitrator calculated that the Company owes Mr. Hussein $11,370 in indemnification, which we subsequently paid on September 30, 2021. Other Regulatory Matters Commencing in April 2017, we have received requests for documents and information from the United States Attorney's Office for the District of Vermont and other government agencies in connection with an investigation concerning the certification we obtained for our software under the United States Department of Health and Human Services' Electronic Health Record (EHR) Incentive Program. The requests for information relate to, among other things: (a) data used to determine objectives and measures under the Meaningful Use (MU) and the Physician Quality Reporting System (PQRS) programs, (b) our EHR product and its performance, (c) the software code used in certifying our EHR software and information, and (d) payments provided for the referral of EHR business. We continue to cooperate in this investigation. Requests and investigations of this nature may lead to future requests for information and ultimately the assertion of claims or the commencement of legal proceedings against us, as well as other material liabilities. In addition, our responses to these and any future requests require time and effort, which can result in additional cost to us. At this time, we are unable to estimate the probability or the amount of liability, if any, related to this matter. Given the highly-regulated nature of our industry, we may, from time to time, be subject to subpoenas, requests for information, or investigations from various government agencies. It is our practice to respond to such matters in a cooperative, thorough and timely manner.

Restructuring Plan

Restructuring Plan	6 Months Ended
	Sep. 30, 2021
Restructuring Costs [Abstract]
Restructuring Plan	16. Restructuring Plan In the six months ended September 30, 2021 and 2020, we recorded restructuring costs of $539 and $2,562, respectively, consisting of payroll-related costs, such as severance, outplacement costs, and continuing healthcare coverage, associated with the involuntary separation of employees pursuant to a one-time benefit arrangement, within operating expenses in our condensed consolidated statements of net income (loss) and comprehensive income (loss). These amounts were accrued when it was probable that the benefits would be paid, and the amounts were reasonably estimable. The payroll-related costs for the three months ended September 30, 2021 have been substantially paid.

Subsequent Events

Subsequent Events	6 Months Ended
	Sep. 30, 2021
Subsequent Events [Abstract]
Subsequent Events	17. Subsequent Events On October 13, 2021, we announced the results of our annual shareholders’ meeting, including the approval of, among other items, the amendment and restatement of the Amended 2015 Plan.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation. The condensed consolidated financial statements include the accounts of NextGen Healthcare, Inc. and its wholly-owned subsidiaries (collectively, the “Company”). Each of the terms “we,” “us,” or “our” as used herein refers collectively to the Company, unless otherwise stated. All intercompany accounts and transactions have been eliminated.
Basis of Presentation	Basis of Presentation. The accompanying unaudited condensed consolidated financial statements as of September 30, 2021 and for the three and six months ended September 30, 2021 have been prepared in accordance with the requirements of Quarterly Report on Form 10-Q and Article 10 of the Securities and Exchange Commission Regulation S-X and therefore do not include all information and notes which would be presented were such condensed consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements presented in our Annual Report on Form 10-K for the fiscal year ended March 31, 2021. In the opinion of management, the accompanying condensed consolidated financial statements reflect all adjustments which are necessary for a fair statement of the results of operations and cash flows for the periods presented. The results of operations for such interim periods are not necessarily indicative of results of operations to be expected for the full year. References to amounts in the condensed consolidated financial statement sections are in thousands, except shares and per share data, unless otherwise specified.
Share-Based Compensation	Share-Based Compensation. The following table summarizes total share-based compensation expense included in the condensed consolidated statements of net income (loss) and comprehensive income (loss) for the three and six months ended September 30, 2021 and 2020: Three Months Ended September 30, Six Months Ended September 30, 2021 2020 2021 2020 Costs and expenses: Cost of revenue $ 554 $ 589 $ 1,058 $ 1,013 Research and development costs 1,110 1,026 2,153 1,943 Selling, general and administrative 3,559 3,822 8,424 7,874 Total share-based compensation 5,223 5,437 11,635 10,830 Income tax benefit (1,151 ) (1,305 ) (2,733 ) (2,569 ) Decrease in net income $ 4,072 $ 4,132 $ 8,902 $ 8,261
Recent Accounting Standards	Recently Adopted Accounting Pronouncements. Recently adopted accounting pronouncements are discussed below or in the notes, where applicable. In December 2019, the Financial Accounting Standards Board ("FASB") issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes Recent Accounting Standards Not Yet Adopted. Recent accounting pronouncements requiring implementation in current or future periods are discussed below or in the notes, where applicable. In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting Reference Rate Reform (Topic 848): Scope Topic 848 amended and restated revolving credit agreement Topic 848 e are currently in the process of evaluating the potential impact of adoption of this updated authoritative guidance on our condensed consolidated financial statements We do not believe that any other recently issued, but not yet effective accounting standards, if adopted, would have a material impact on our condensed consolidated financial statements.
Revenue Recognition and Performance Obligations	Revenue Recognition and Performance Obligations We generate revenue from sales of licensing rights and subscriptions to our software solutions, hardware and third-party software products, support and maintenance, managed services, EDI, and other non-recurring services, including implementation, training, and consulting services. Our contracts with customers may include multiple performance obligations that consist of various combinations of our software solutions and related services, which are generally capable of being distinct and accounted for as separate performance obligations. The total transaction price is allocated to each performance obligation within a contract based on estimated standalone selling prices. Revenue is recognized when control of the promised goods or services is transferred to our customers in an amount that reflects the consideration that we expect to be entitled to in exchange for those goods or services. We exclude sales tax from the measurement of the transaction price and
Revenue Recognition	Recurring revenues consists of subscription services, support and maintenance, managed services, and EDI and data services. Software, hardware, and other non-recurring revenues consists of revenue from sales of software license and hardware and certain non-recurring services, such as implementation, training, and consulting performed for clients who use our products. We generally recognize revenue for our most significant performance obligations as follows: Subscription services. Performance obligations involving subscription services, which include annual libraries, are satisfied over time as the customer simultaneously receives and consumes the benefits of the services throughout the contract period. Our subscription services primarily include our software-as-a-service (“SaaS”) based offerings, such as our electronic health records and practice management, mobile, patient portal, and population health management solutions. Our SaaS-based offerings may include multiple goods and services, such as providing access to our technology-based solutions together with our managed cloud hosting services. These offerings are concurrently delivered with the same pattern of transfer to our customers and are accounted for as a single performance obligation because the technology-based solutions and other goods and services included within our overall SaaS-based offerings are each individually not capable of being distinct as the customer receives benefits based on the combined offering. Our annual libraries primarily consist of providing stand-ready access to certain content, knowledgebase, databases, and SaaS-based educational tools, which are frequently updated to meet the most current standards and requirements, to be utilized in conjunction with our core solutions. We recognize revenue related to these subscription services, including annual libraries, ratably over the respective noncancelable contract term. Support and maintenance. Performance obligations involving support and maintenance are satisfied over time as the customer simultaneously receives and consumes the benefits of the maintenance services provided. Our support and maintenance services may consist of separate performance obligations, such as unspecified upgrades or enhancements and technical support, which are considered stand-ready in nature and can be offered at various points during the service period. Since the efforts associated with the combined support and maintenance services are rendered concurrently and provided evenly throughout the service period, we consider the series of support and maintenance services to be a single performance obligation. Therefore, we recognize revenue related to these services ratably over the respective noncancelable contract term. Managed services. Managed services consist primarily of RCM and related services, but also includes our hosting services, which we refer to as managed cloud services, transcription services, patient pay services, and certain other recurring services. Performance obligations associated with RCM services are satisfied over time as the customer simultaneously receives and consumes the benefits of the services executed throughout the contract period. The majority of service fees under our RCM arrangements are variable consideration contingent upon collections by our clients. We estimate the variable consideration which we expect to be entitled to over the noncancelable contract term associated with our RCM service arrangements. The estimate of variable consideration included in the transaction price typically involves estimating the amounts we will ultimately collect on behalf of our clients and the relative fee we charge that is generally calculated as a percentage of those collections. Inputs to these estimates include, but are not limited to, historical service fees and collections amounts, timing of historical collections relative to the timing of when claims are submitted by our clients to their respective payers, macroeconomic trends, and anticipated changes in the number of providers. Significant judgement is required when estimating the total transaction price based on the variable consideration. We may apply certain constraints when appropriate whereby we include in the transaction price estimated variable consideration only to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. Such estimates are assessed at the contract level. RCM and related services may not be rendered evenly over the contract period as the timing of services are based on customer collections, which may vary throughout the service period. We recognize revenue for RCM based on the amount of collections received throughout the contract term as it most closely depicts our efforts to transfer our service obligations to the customer. Our managed cloud services represent a single performance obligation to provide cloud hosting services to our customers and related revenue is recognized ratably over the respective noncancelable contract term. Performance obligations related to the transcription services, patient pay services, and other recurring services are satisfied as the corresponding services are provided and revenue is recognized as such services are rendered. Electronic data interchange and data services. Performance obligations related to EDI and other transaction processing services are satisfied at the point in time the services are rendered. The transfer of control occurs when the transaction processing services are delivered and the customer receives the benefits from the services provided. Software license and hardware. Software license and hardware are considered point-in-time performance obligations as control is transferred to customers upon the delivery of the software license and hardware. Our software licenses are considered functional licenses, and revenue recognition generally occurs on the date of contract execution as the customer is provided with immediate access to the license. We generally determine the amount of consideration allocated to the software license performance obligation using the residual approach, except for certain RCM arrangements where the amount allocated to the software license performance obligation is determined based on estimated relative standalone selling prices. For hardware, we recognize revenue upon transfer of such hardware or devices to the customer. Other non-recurring services. Performance obligations related to other non-recurring services, including implementation, training, and consulting services, are generally satisfied as the corresponding services are provided. Once the services have been provided to the customer, the transfer of control has occurred. Therefore, we recognize revenue as such services are rendered.
Non-Recurring Fair Value Measurements	Non-Recurring Fair Value Measurements We have certain assets, including goodwill and other intangible assets, which are measured at fair value on a non-recurring basis and are adjusted to fair value only if an impairment charge is recognized. The categorization of the framework used to measure fair value of the assets is considered to be within the Level 3 valuation hierarchy due to the subjective nature of the unobservable inputs used.
Leases	Our leasing arrangements are reflected on the balance sheet as right-of-use assets and liabilities pertaining to the rights and obligations created by the leased assets. Right-of-use lease assets and corresponding lease liabilities are recognized at commencement date based on the present value of lease payments over the expected lease term. Since the interest rate implicit in our lease arrangements is not readily determinable, we determine an incremental borrowing rate for each lease based on the approximate interest rate on a collateralized basis with similar remaining terms and payments as of the lease commencement date to determine the present value of future lease payments. Our lease terms may include options to extend or terminate the lease. Currently, it is not reasonably certain that we will exercise those options and therefore, we utilize the initial , non cancelable , lease term to calculate the lease assets and corresponding liabilities for all our leases. We have certain insignificant short-term leases with an initial term of twelve months or less that are not recorded in our condensed consolidated balance sheets. Operating right-of-use lease assets are classified as operating lease assets on our condensed consolidated balance sheets. We determine whether an arrangement is a lease at inception and classify it as finance or operating. All of our existing material leases are classified as operating leases. Our leases do not contain any residual value guarantees. Our lease agreements generally contain lease and non-lease components. Non-lease components primarily include payments for maintenance and utilities. We have applied the practical expedient to combine fixed payments for non-lease components with our lease payments for all of our leases and account for them together as a single lease component, which increases the amount of our lease assets and corresponding liabilities. Payments under our lease arrangements are primarily fixed, however, certain lease agreements contain variable payments, which are expensed as incurred and not included in the operating lease assets and liabilities.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Schedule of Stock-Based Compensation Expense	The following table summarizes total share-based compensation expense included in the condensed consolidated statements of net income (loss) and comprehensive income (loss) for the three and six months ended September 30, 2021 and 2020: Three Months Ended September 30, Six Months Ended September 30, 2021 2020 2021 2020 Costs and expenses: Cost of revenue $ 554 $ 589 $ 1,058 $ 1,013 Research and development costs 1,110 1,026 2,153 1,943 Selling, general and administrative 3,559 3,822 8,424 7,874 Total share-based compensation 5,223 5,437 11,635 10,830 Income tax benefit (1,151 ) (1,305 ) (2,733 ) (2,569 ) Decrease in net income $ 4,072 $ 4,132 $ 8,902 $ 8,261

Revenue from Contracts with C_2

Revenue from Contracts with Customers (Tables)	6 Months Ended
	Sep. 30, 2021
Revenue From Contract With Customer [Abstract]
Schedule of Revenues Disaggregated by Major Revenue Categories and by Occurrence	The following table presents our revenues disaggregated by our major revenue categories and by occurrence: Three Months Ended September 30, Six Months Ended September 30, 2021 2020 2021 2020 Recurring revenues: Subscription services $ 41,139 $ 36,867 $ 79,423 $ 72,227 Support and maintenance 39,004 38,076 77,490 76,623 Managed services 29,506 26,218 58,937 48,711 Electronic data interchange and data services 25,960 24,530 52,140 47,652 Total recurring revenues 135,609 125,691 267,990 245,213 Software, hardware, and other non-recurring revenues: Software license and hardware 8,068 8,014 15,282 12,754 Other non-recurring services 5,609 6,297 12,098 12,914 Total software, hardware and other non-recurring revenues 13,677 14,311 27,380 25,668 Total revenues $ 149,286 $ 140,002 $ 295,370 $ 270,881

Accounts Receivable (Tables)

Accounts Receivable (Tables)	6 Months Ended
	Sep. 30, 2021
Receivables [Abstract]
Summary of Accounts Receivable	Accounts receivable includes invoiced amounts where the right to receive payment is unconditional and only subject to the passage of time. Allowance for doubtful accounts are reported as a component of accounts receivable as summarized below: September 30, 2021 March 31, 2021 Accounts receivable, gross $ 75,641 $ 81,746 Allowance for doubtful accounts (3,653 ) (4,205 ) Accounts receivable, net $ 71,988 $ 77,541
Summary of Changes in Allowance for Doubtful Accounts	The following table represents the changes in the allowance for doubtful accounts, as of and for the three months ended September 30, 2021: Balance as of June 30, 2021 $ (4,099 ) Additions charged to costs and expenses (40 ) Deductions 486 Balance as of September 30, 2021 $ (3,653 ) The following table represents the changes in the allowance for doubtful accounts, as of and for the six months ended September 30, 2021: Balance as of March 31, 2021 $ (4,205 ) Additions charged to costs and expenses (679 ) Deductions 1,231 Balance as of September 30, 2021 $ (3,653 )

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Sep. 30, 2021
Fair Value Disclosures [Abstract]
Fair Value of Assets and Liabilities on a Recurring Basis	The following tables set forth by level within the fair value hierarchy our financial assets and liabilities that were accounted for at fair value on a recurring basis at September 30, 2021 and March 31, 2021: Balance At Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Unobservable Inputs September 30, 2021 (Level 1) (Level 2) (Level 3) ASSETS Cash and cash equivalents (1) $ 75,303 $ 75,303 $ — $ — Restricted cash and cash equivalents 6,261 6,261 — — $ 81,564 $ 81,564 $ — $ — LIABILITIES Contingent consideration related to acquisitions $ 533 $ — $ 533 $ — $ 533 $ — $ 533 $ — Balance At Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Unobservable Inputs March 31, 2021 (Level 1) (Level 2) (Level 3) ASSETS Cash and cash equivalents (1) $ 73,295 $ 73,295 $ — $ — Restricted cash and cash equivalents 5,280 5,280 — — $ 78,575 $ 78,575 $ — $ — LIABILITIES Contingent consideration related to acquisitions $ 533 $ — $ 533 $ — $ 533 $ — $ 533 $ — (1) Cash equivalents consist primarily of money market funds.

Leases (Tables)

Leases (Tables)	6 Months Ended
	Sep. 30, 2021
Leases [Abstract]
Summary of Components of Operating Lease Costs	Components of operating lease costs are summarized as follows: Three Months Ended September 30, Six Months Ended September 30, 2021 2020 2021 2020 Operating lease costs $ 1,602 $ 2,093 $ 3,435 $ 4,184 Short-term lease costs 2 6 8 13 Variable lease costs 204 289 361 586 Less: Sublease income (123 ) (123 ) (255 ) (248 ) Total operating lease costs $ 1,685 $ 2,265 $ 3,549 $ 4,535
Supplemental Cash Flow Information Related to Operating Leases	Supplemental cash flow information related to operating leases is summarized as follows: Three Months Ended September 30, Six Months Ended September 30, 2021 2020 2021 2020 Cash paid for amounts included in the measurement of operating lease liabilities $ 2,950 $ 3,132 $ 5,914 $ 6,264 Operating lease assets obtained in exchange for operating lease liabilities 197 3,107 197 3,107
Summary of Future Minimum Aggregate Lease Payments Operating Leases	Future minimum aggregate lease payments under operating leases as of September 30, 2021 are summarized as follows: For the year ended March 31, 2022 (remaining six months) $ 7,853 2023 8,283 2024 6,337 2025 3,824 2026 1,257 Total future lease payments 27,554 Less interest (1,618 ) Total lease liabilities $ 25,936

Intangible Assets (Tables)

Intangible Assets (Tables)	6 Months Ended
	Sep. 30, 2021
Goodwill And Intangible Assets Disclosure [Abstract]
Intangible Assets, Other than Capitalized Software Development Costs	Our definite-lived intangible assets, other than capitalized software development costs, are summarized as follows: September 30, 2021 Customer Relationships Trade Names Software Technology Total Gross carrying amount $ 39,200 $ 250 $ 49,000 $ 88,450 Accumulated amortization (28,086 ) (92 ) (29,770 ) (57,948 ) Net intangible assets $ 11,114 $ 158 $ 19,230 $ 30,502 March 31, 2021 Customer Relationships Trade Names Software Technology Total Gross carrying amount $ 39,200 $ 250 $ 91,500 $ 130,950 Accumulated amortization (26,349 ) (67 ) (67,834 ) (94,250 ) Net intangible assets $ 12,851 $ 183 $ 23,666 $ 36,700
Estimated Amortization of Intangible Assets with Determinable Lives	The following table summarizes the remaining estimated amortization of definite-lived intangible assets as of September 30, 2021: Estimated Remaining Amortization Expense Operating Expense Cost of Revenue Total For the year ended March 31, 2022 (remaining six months) $ 1,762 $ 4,436 $ 6,198 2023 2,820 5,154 7,974 2024 2,279 3,573 5,852 2025 1,846 3,573 5,419 2026 1,377 2,251 3,628 2027 and beyond 1,188 243 1,431 Total $ 11,272 $ 19,230 $ 30,502

Capitalized Software Costs (Tab

Capitalized Software Costs (Tables)	6 Months Ended
	Sep. 30, 2021
Research And Development [Abstract]
Capitalized Software Development Costs	Our capitalized software costs are summarized as follows: September 30, 2021 March 31, 2021 Gross carrying amount $ 106,810 $ 96,908 Accumulated amortization (65,240 ) (55,434 ) Net capitalized software costs $ 41,570 $ 41,474
Estimated Amortization of Capitalized Software Costs	The following table presents the remaining estimated amortization of capitalized software costs as of September 30, 2021. The estimated amortization is comprised of (i) amortization of released products and (ii) the expected amortization for products that are not yet available for sale based on their estimated economic lives and projected general release dates. For the year ended March 31, 2022 (remaining six months) $ 14,000 2023 17,400 2024 7,800 2025 2,200 2026 170 Total $ 41,570

Composition of Certain Financ_2

Composition of Certain Financial Statement Captions (Tables)	6 Months Ended
	Sep. 30, 2021
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Summary of Cash, Cash Equivalents, and Restricted Cash	Cash, cash equivalents, and restricted cash are summarized as follows: September 30, 2021 March 31, 2021 Cash and cash equivalents $ 75,303 $ 73,295 Restricted cash and cash equivalents 6,261 5,280 Cash, cash equivalents, and restricted cash $ 81,564 $ 78,575
Summary of Prepaid Expenses and Other Current Assets	Prepaid expenses and other current assets are summarized as follows: September 30, 2021 March 31, 2021 Prepaid expenses $ 15,969 $ 20,679 Capitalized commissions costs 10,880 9,399 Other current assets 725 1,204 Prepaid expenses and other current assets $ 27,574 $ 31,282
Summary of Equipment and Improvements	Equipment and improvements are summarized as follows: September 30, 2021 March 31, 2021 Computer equipment $ 35,977 $ 35,244 Internal-use software 18,828 18,174 Furniture and fixtures 10,720 11,555 Leasehold improvements 14,406 14,418 Equipment and improvements, gross 79,931 79,391 Accumulated depreciation and amortization (67,901 ) (64,852 ) Equipment and improvements, net $ 12,030 $ 14,539
Summary of Other Assets	Other assets are summarized as follows: September 30, 2021 March 31, 2021 Capitalized commission costs $ 19,557 $ 19,104 Deposits 5,896 5,505 Debt issuance costs 2,260 2,521 Other noncurrent assets 9,915 9,891 Other assets $ 37,628 $ 37,021
Summary of Accrued Compensation and Related Benefits	Accrued compensation and related benefits are summarized as follows: September 30, 2021 March 31, 2021 Accrued bonus $ 14,377 $ 29,382 Accrued vacation 11,667 12,038 Accrued commissions 3,655 4,628 Deferred payroll taxes 3,817 3,817 Accrued payroll and other 537 509 Accrued compensation and related benefits $ 34,053 $ 50,374
Summary of Other Current and Noncurrent Liabilities	Other current and noncurrent liabilities are summarized as follows: September 30, 2021 March 31, 2021 Accrued legal expense $ 8,501 $ 6,302 Accrued hosting costs 8,228 6,158 Care services liabilities 6,261 5,280 Sales returns reserves and other customer liabilities 6,016 9,449 Accrued proxy contest expense 5,873 — Customer credit balances and deposits 4,917 4,638 Accrued consulting and outside services 3,972 3,002 Accrued employee benefits and withholdings 3,518 4,649 Accrued self insurance expense 2,468 1,737 Accrued outsourcing costs 2,234 2,266 Accrued EDI expense 1,927 2,020 Accrued royalties 829 3,125 Accrued taxes payable 640 586 Contingent consideration related to acquisitions 533 533 Other accrued expenses 3,523 2,954 Other current liabilities $ 59,440 $ 52,699 Deferred payroll taxes $ 3,817 3,817 Uncertain tax positions 3,175 3,175 Other liabilities 156 144 Other noncurrent liabilities $ 7,148 $ 7,136

Earnings Per Share (Tables)

Earnings Per Share (Tables)	6 Months Ended
	Sep. 30, 2021
Earnings Per Share [Abstract]
Weighted Average Shares Outstanding for Basic and Diluted Net Income Per Share	The dual presentation of “basic” and “diluted” earnings per share is provided below. Share amounts below are in thousands. Three Months Ended September 30, Six Months Ended September 30, 2021 2020 2021 2020 Earnings per share — Basic: Net income (loss) $ (6,771 ) $ 10,455 $ (3,923 ) $ 9,631 Weighted-average shares outstanding — Basic 67,406 66,688 67,291 66,493 Net income (loss) per common share — Basic $ (0.10 ) $ 0.16 $ (0.06 ) $ 0.14 Earnings per share — Diluted: Net income (loss) $ (6,771 ) $ 10,455 $ (3,923 ) $ 9,631 Weighted-average shares outstanding 67,406 66,688 67,291 66,493 Effect of potentially dilutive securities — 1 — — Weighted-average shares outstanding — Diluted 67,406 66,689 67,291 66,493 Net income (loss) per common share — Diluted $ (0.10 ) $ 0.16 $ (0.06 ) $ 0.14

Share Based Awards (Tables)

Share Based Awards (Tables)	6 Months Ended
	Sep. 30, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Summary of Stock Option Activity	Stock Options The following table summarizes the stock option transactions during the six months ended September 30, 2021: Weighted- Weighted- Average Average Aggregate Exercise Remaining Intrinsic Number of Price Contractual Value Shares per Share Life (years) (in thousands) Outstanding, March 31, 2021 2,791,084 $ 14.47 3.7 $ 10,303 Exercised (1,010,700 ) 13.41 3.2 1,618 Forfeited/Canceled (20,820 ) 21.08 4.7 Expired (56,500 ) 18.85 Outstanding, September 30, 2021 1,703,064 $ 14.88 3.4 $ 309 Vested and expected to vest, September 30, 2021 1,671,176 $ 14.87 3.4 $ 309 Exercisable, September 30, 2021 1,502,682 $ 14.85 3.2 $ 307
Schedule of Employee Stock Options and Performance Based Awards by Non-vested Stock Options	Non-vested stock option award activity during the six months ended September 30, 2021 is summarized as follows: Weighted- Average Grant-Date Number of Fair Value Shares per Share Outstanding, March 31, 2021 459,339 $ 5.96 Vested (248,957 ) 5.87 Forfeited/Canceled (10,000 ) 8.74 Outstanding, September 30, 2021 200,382 $ 5.94
Summary of Restricted Stock Awards Activity	Restricted Stock Awards Restricted stock awards activity during the six months ended September 30, 2021 is summarized as follows: Weighted- Average Grant-Date Number of Fair Value Shares per Share Outstanding, March 31, 2021 2,263,569 $ 14.58 Granted 1,605,649 15.46 Vested (871,842 ) 14.98 Canceled (144,356 ) 14.74 Outstanding, September 30, 2021 2,853,020 $ 14.95

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Schedule of Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Costs and expenses:
Total share-based compensation	$ 5,223	$ 5,437	$ 11,635	$ 10,830
Income tax benefit	(1,151)	(1,305)	(2,733)	(2,569)
Decrease in net income	4,072	4,132	8,902	8,261
Cost of Revenue
Costs and expenses:
Total share-based compensation	554	589	1,058	1,013
Research and Development Costs
Costs and expenses:
Total share-based compensation	1,110	1,026	2,153	1,943
Selling, General and Administrative
Costs and expenses:
Total share-based compensation	$ 3,559	$ 3,822	$ 8,424	$ 7,874

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Additional Information (Details) - Accounting Standards Update 2019-12	Sep. 30, 2021
Accounting Policies [Line Items]
Change in Accounting Principle, Accounting Standards Update, Adopted [true false]	true
Change in Accounting Principle, Accounting Standards Update, Early Adoption [true false]	false
Change in Accounting Principle, Accounting Standards Update, Adoption Date	Apr. 1, 2021
Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false]	true

Revenue from Contracts with C_3

Revenue from Contracts with Customers - Schedule of Revenues Disaggregated by Major Revenue Categories and by Occurrence (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Disaggregation Of Revenue [Line Items]
Total revenues	$ 149,286	$ 140,002	$ 295,370	$ 270,881
Subscription Services
Disaggregation Of Revenue [Line Items]
Total revenues	41,139	36,867	79,423	72,227
Support And Maintenance
Disaggregation Of Revenue [Line Items]
Total revenues	39,004	38,076	77,490	76,623
Managed Services
Disaggregation Of Revenue [Line Items]
Total revenues	29,506	26,218	58,937	48,711
Electronic Data Interchange And Data Services
Disaggregation Of Revenue [Line Items]
Total revenues	25,960	24,530	52,140	47,652
Recurring Revenue
Disaggregation Of Revenue [Line Items]
Total revenues	135,609	125,691	267,990	245,213
Software License and Hardware
Disaggregation Of Revenue [Line Items]
Total revenues	8,068	8,014	15,282	12,754
Other Non-recurring Services
Disaggregation Of Revenue [Line Items]
Total revenues	5,609	6,297	12,098	12,914
Software, Hardware, and Other Non-recurring
Disaggregation Of Revenue [Line Items]
Total revenues	$ 13,677	$ 14,311	$ 27,380	$ 25,668

Revenue from Contracts with C_4

Revenue from Contracts with Customers - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Revenue From Contract With Customer [Line Items]
Revenue, Remaining Performance Obligation, Amount	$ 531,800	$ 471,700	$ 531,800	$ 471,700
Percentage of revenue expected to recognize as services rendered and goods delivered	10.00%	10.00%	10.00%	10.00%
Percentage of revenue expected to recognize over next 12 months	52.00%	53.00%	52.00%	53.00%
Contract liability balance or invoiced to customers	$ 17,607	$ 19,319	$ 35,388	$ 40,145
Capitalized commission costs			30,437
Commission expenses	$ 3,056	$ 2,636	5,982	$ 4,876
Prepaid Expenses And Other Current Assets
Revenue From Contract With Customer [Line Items]
Capitalized commission costs			10,880
Other Noncurrent Assets
Revenue From Contract With Customer [Line Items]
Capitalized commission costs			$ 19,557
Minimum
Revenue From Contract With Customer [Line Items]
Capitalized contract cost, amortization period	1 year		1 year
Maximum
Revenue From Contract With Customer [Line Items]
Capitalized contract cost, amortization period	5 years		5 years

Accounts Receivable - Summary o

Accounts Receivable - Summary of Accounts Receivable (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021
Receivables [Abstract]
Accounts receivable, gross	$ 75,641		$ 81,746
Allowance for doubtful accounts	(3,653)	$ (4,099)	(4,205)
Accounts receivable, net	$ 71,988		$ 77,541

Accounts Receivable - Summary_2

Accounts Receivable - Summary of Changes in Allowance for Doubtful Accounts (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Sep. 30, 2021	Sep. 30, 2021	Sep. 30, 2020
Receivables [Abstract]
Balance	$ (4,099)	$ (4,205)
Additions charged to costs and expenses	(40)	(679)	$ (1,399)
Deductions	486	1,231
Balance	$ (3,653)	$ (3,653)

Fair Value Measurements - Fair

Fair Value Measurements - Fair Value of Assets and Liabilities on a Recurring Basis (Details) - Fair Value, Measurements, Recurring - USD ($) $ in Thousands		Sep. 30, 2021	Mar. 31, 2021
Carrying Value
ASSETS
Cash and cash equivalents	[1]	$ 75,303	$ 73,295
Restricted cash and cash equivalents		6,261	5,280
Total		81,564	78,575
LIABILITIES
Contingent consideration related to acquisitions		533	533
Total		533	533
Quoted Prices in Active Markets for Identical Assets (Level 1) | Fair Value
ASSETS
Cash and cash equivalents	[1]	75,303	73,295
Restricted cash and cash equivalents		6,261	5,280
Total		81,564	78,575
LIABILITIES
Contingent consideration related to acquisitions		0	0
Total		0	0
Significant Other Observable Inputs (Level 2) | Fair Value
ASSETS
Cash and cash equivalents	[1]	0	0
Restricted cash and cash equivalents		0	0
Total		0	0
LIABILITIES
Contingent consideration related to acquisitions		533	533
Total		533	533
Unobservable Inputs (Level 3) | Fair Value
ASSETS
Cash and cash equivalents	[1]	0	0
Restricted cash and cash equivalents		0	0
Total		0	0
LIABILITIES
Contingent consideration related to acquisitions		0	0
Total		$ 0	$ 0
[1]	Cash equivalents consist primarily of money market funds.

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Details) - Topaz Information Systems, LLC - USD ($) $ in Thousands	Sep. 30, 2021	Mar. 31, 2021
Business Acquisition [Line Items]
Contingent consideration related to acquisitions	$ 533	$ 533
Maximum
Business Acquisition [Line Items]
Expected earnout payments subject to achievement of certain operational targets	$ 2,000

Leases - Additional Information

Leases - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Lessee Lease Description [Line Items]
Total operating lease costs	$ 1,685	$ 2,265	$ 3,549	$ 4,535
Operating lease, weighted average remaining lease term	3 years		3 years
Operating lease, weighted average discount rate, percent	3.60%		3.60%
Lease Right of Use Assets and Property Plant and Equipment
Lessee Lease Description [Line Items]
Other asset impairment charges	$ 1,195		$ 1,577
Minimum
Lessee Lease Description [Line Items]
Lease expiration year			2022
Maximum
Lessee Lease Description [Line Items]
Lease expiration year			2026

Leases - Summary of Components

Leases - Summary of Components of Operating Lease Costs (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Leases [Abstract]
Operating lease costs	$ 1,602	$ 2,093	$ 3,435	$ 4,184
Short-term lease costs	2	6	8	13
Variable lease costs	204	289	361	586
Less: Sublease income	(123)	(123)	(255)	(248)
Total operating lease costs	$ 1,685	$ 2,265	$ 3,549	$ 4,535

Leases - Supplemental Cash Flow

Leases - Supplemental Cash Flow Information Related to Operating Leases (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Leases [Abstract]
Cash paid for amounts included in the measurement of operating lease liabilities	$ 2,950	$ 3,132	$ 5,914	$ 6,264
Operating lease assets obtained in exchange for operating lease liabilities	$ 197	$ 3,107	$ 197	$ 3,107

Leases - Summary of Future Mini

Leases - Summary of Future Minimum Aggregate Lease Payments Operating Leases (Details) $ in Thousands	Sep. 30, 2021USD ($)
Leases [Abstract]
2022 (remaining six months)	$ 7,853
2023	8,283
2024	6,337
2025	3,824
2026	1,257
Total future lease payments	27,554
Less interest	(1,618)
Total lease liabilities	$ 25,936

Goodwill - Additional Informati

Goodwill - Additional Information (Details) $ in Thousands	6 Months Ended
	Sep. 30, 2021USD ($)segment	Mar. 31, 2021USD ($)
Goodwill And Intangible Assets Disclosure [Abstract]
Number of operating segments | segment	1
Goodwill | $	$ 267,212	$ 267,212

Intangible Assets - Intangible

Intangible Assets - Intangible Assets, Other than Capitalized Software Development Costs (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Mar. 31, 2021
Finite Lived Intangible Assets [Line Items]
Gross carrying amount	$ 88,450	$ 130,950
Accumulated amortization	(57,948)	(94,250)
Net intangible assets	30,502	36,700
Customer Relationships
Finite Lived Intangible Assets [Line Items]
Gross carrying amount	39,200	39,200
Accumulated amortization	(28,086)	(26,349)
Net intangible assets	11,114	12,851
Trade Names
Finite Lived Intangible Assets [Line Items]
Gross carrying amount	250	250
Accumulated amortization	(92)	(67)
Net intangible assets	158	183
Computer Software, Intangible Asset
Finite Lived Intangible Assets [Line Items]
Gross carrying amount	49,000	91,500
Accumulated amortization	(29,770)	(67,834)
Net intangible assets	$ 19,230	$ 23,666

Intangible Assets - Additional

Intangible Assets - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Finite Lived Intangible Assets [Line Items]
Amortization of other intangibles			$ 6,198	$ 12,232
Customer Relationships and Trade Names | Operating Expense
Finite Lived Intangible Assets [Line Items]
Amortization of other intangibles	$ 881	$ 1,112	1,762	2,224
Computer Software, Intangible Asset | Cost of Revenue
Finite Lived Intangible Assets [Line Items]
Amortization of other intangibles	$ 2,218	$ 4,872	$ 4,436	$ 10,008

Intangible Assets - Estimated A

Intangible Assets - Estimated Amortization of Intangible Assets with Determinable Lives (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Mar. 31, 2021
Finite Lived Intangible Assets [Line Items]
2022 (remaining six months)	$ 6,198
2023	7,974
2024	5,852
2025	5,419
2026	3,628
2027 and beyond	1,431
Net intangible assets	30,502	$ 36,700
Operating Expense
Finite Lived Intangible Assets [Line Items]
2022 (remaining six months)	1,762
2023	2,820
2024	2,279
2025	1,846
2026	1,377
2027 and beyond	1,188
Net intangible assets	11,272
Cost of Revenue
Finite Lived Intangible Assets [Line Items]
2022 (remaining six months)	4,436
2023	5,154
2024	3,573
2025	3,573
2026	2,251
2027 and beyond	243
Net intangible assets	$ 19,230

Capitalized Software Costs - Ca

Capitalized Software Costs - Capitalized Software Development Costs (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Mar. 31, 2021
Research And Development [Abstract]
Gross carrying amount	$ 106,810	$ 96,908
Accumulated amortization	(65,240)	(55,434)
Net capitalized software costs	$ 41,570	$ 41,474

Capitalized Software Costs - Ad

Capitalized Software Costs - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Research And Development [Abstract]
Amortization of capitalized software costs	$ 5,751	$ 5,090	$ 11,617	$ 9,853

Capitalized Software Costs - Es

Capitalized Software Costs - Estimated Amortization of Capitalized Software Costs (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Mar. 31, 2021
Finite Lived Intangible Assets [Line Items]
2022 (remaining six months)	$ 6,198
2023	7,974
2024	5,852
2025	5,419
2026	3,628
Net intangible assets	30,502	$ 36,700
Capitalized Software Costs
Finite Lived Intangible Assets [Line Items]
2022 (remaining six months)	14,000
2023	17,400
2024	7,800
2025	2,200
2026	170
Net intangible assets	$ 41,570

Line of Credit - Additional Inf

Line of Credit - Additional Information (Details) - USD ($)	3 Months Ended		6 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Mar. 31, 2021	Mar. 12, 2021	Mar. 29, 2018
Line Of Credit Facility [Line Items]
Loans outstanding	$ 0		$ 0		$ 0
Remaining borrowing capacity	300,000,000		300,000,000		$ 300,000,000
Interest expense	193,000	$ 928,000	383,000	$ 1,856,000
Amortization of debt issuance costs	127,000	$ 178,000	254,000	$ 355,000
Revolving Credit Facility
Line Of Credit Facility [Line Items]
Maximum borrowing capacity	$ 150,000,000		$ 150,000,000			$ 300,000,000	$ 300,000,000
Credit agreement maturity date			Mar. 12, 2026
Letter of Credit
Line Of Credit Facility [Line Items]
Maximum borrowing capacity						10,000,000
Swing-Line Loans
Line Of Credit Facility [Line Items]
Maximum borrowing capacity						$ 10,000,000

Composition of Certain Financ_3

Composition of Certain Financial Statement Captions - Summary of Cash, Cash Equivalents, and Restricted Cash (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Mar. 31, 2020
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents [Abstract]
Cash and cash equivalents	$ 75,303	$ 73,295
Restricted cash and cash equivalents	6,261	5,280
Cash, cash equivalents, and restricted cash	$ 81,564	$ 78,575	$ 108,845	$ 140,319

Composition of Certain Financ_4

Composition of Certain Financial Statement Captions - Summary of Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Mar. 31, 2021
Prepaid Expense And Other Assets Current [Abstract]
Prepaid expenses	$ 15,969	$ 20,679
Capitalized commissions costs	10,880	9,399
Other current assets	725	1,204
Prepaid expenses and other current assets	$ 27,574	$ 31,282

Composition of Certain Financ_5

Composition of Certain Financial Statement Captions - Summary of Equipment and Improvements (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Mar. 31, 2021
Property Plant And Equipment [Line Items]
Equipment and improvements, gross	$ 79,931	$ 79,391
Accumulated depreciation and amortization	(67,901)	(64,852)
Equipment and improvements, net	12,030	14,539
Computer Equipment
Property Plant And Equipment [Line Items]
Equipment and improvements, gross	35,977	35,244
Internal-Use Software
Property Plant And Equipment [Line Items]
Equipment and improvements, gross	18,828	18,174
Furniture and Fixtures
Property Plant And Equipment [Line Items]
Equipment and improvements, gross	10,720	11,555
Leasehold Improvements
Property Plant And Equipment [Line Items]
Equipment and improvements, gross	$ 14,406	$ 14,418

Composition of Certain Financ_6

Composition of Certain Financial Statement Captions - Summary of Other Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Mar. 31, 2021
Other Assets Noncurrent Disclosure [Abstract]
Capitalized commission costs	$ 19,557	$ 19,104
Deposits	5,896	5,505
Debt issuance costs	2,260	2,521
Other noncurrent assets	9,915	9,891
Other assets	$ 37,628	$ 37,021

Composition of Certain Financ_7

Composition of Certain Financial Statement Captions - Summary of Accrued Compensation and Related Benefits (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Mar. 31, 2021
Employee Related Liabilities Current [Abstract]
Accrued bonus	$ 14,377	$ 29,382
Accrued vacation	11,667	12,038
Accrued commissions	3,655	4,628
Deferred payroll taxes	3,817	3,817
Accrued payroll and other	537	509
Accrued compensation and related benefits	$ 34,053	$ 50,374

Composition of Certain Financ_8

Composition of Certain Financial Statement Captions - Summary of Other Current and Noncurrent Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Mar. 31, 2021
Other Liabilities [Abstract]
Accrued legal expense	$ 8,501	$ 6,302
Accrued hosting costs	8,228	6,158
Care services liabilities	6,261	5,280
Sales returns reserves and other customer liabilities	6,016	9,449
Accrued proxy contest expense	5,873
Customer credit balances and deposits	4,917	4,638
Accrued consulting and outside services	3,972	3,002
Accrued employee benefits and withholdings	3,518	4,649
Accrued self insurance expense	2,468	1,737
Accrued outsourcing costs	2,234	2,266
Accrued EDI expense	1,927	2,020
Accrued royalties	829	3,125
Accrued taxes payable	640	586
Contingent consideration related to acquisitions	533	533
Other accrued expenses	3,523	2,954
Other current liabilities	59,440	52,699
Deferred payroll taxes	3,817	3,817
Uncertain tax positions	3,175	3,175
Other liabilities	156	144
Other noncurrent liabilities	$ 7,148	$ 7,136

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Mar. 31, 2021
Income Tax Disclosure [Abstract]
Provision for (benefit of) income taxes	$ (1,441)	$ (1,298)	$ (882)	$ 318
Effective tax rate (as a percentage)	17.50%	14.20%	18.40%	3.20%
Liability for unrecognized tax benefits	$ 4,438		$ 4,438		$ 4,426
Unrecognized tax benefits consisted of liability	3,164		3,164		3,175
Unrecognized tax benefits reserves against deferred tax assets	$ 1,274		$ 1,274		$ 1,251
Period within which the company does not anticipate total unrecognized tax benefits to change			within the next twelve months

Earnings Per Share - Weighted A

Earnings Per Share - Weighted Average Shares Outstanding for Basic and Diluted Net Income Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended				6 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Sep. 30, 2020	Jun. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Earnings per share — Basic:
Net income (loss)	$ (6,771)	$ 2,848	$ 10,455	$ (824)	$ (3,923)	$ 9,631
Weighted-average shares outstanding — Basic	67,406		66,688		67,291	66,493
Net income (loss) per common share — Basic	$ (0.10)		$ 0.16		$ (0.06)	$ 0.14
Earnings per share — Diluted:
Net income (loss)	$ (6,771)	$ 2,848	$ 10,455	$ (824)	$ (3,923)	$ 9,631
Weighted-average shares outstanding — Basic	67,406		66,688		67,291	66,493
Effect of potentially dilutive securities			1
Weighted-average shares outstanding — Diluted	67,406		66,689		67,291	66,493
Net income (loss) per common share — Diluted	$ (0.10)		$ 0.16		$ (0.06)	$ 0.14

Earnings Per Share - Additional

Earnings Per Share - Additional Information (Details) - shares shares in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Employee Stock Options
Options excluded from the computation of diluted net income (loss) per share	697	2,787	254	2,954

Share Based Awards - Additional

Share Based Awards - Additional Information (Details) - USD ($)	Sep. 20, 2021	Oct. 26, 2020	Oct. 23, 2018	Aug. 11, 2014	Jan. 27, 2020	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Mar. 31, 2021	Aug. 31, 2019	Aug. 31, 2017	Aug. 31, 2015	Oct. 31, 2005
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Outstanding stock options						1,703,064		1,703,064		2,791,084
Total share-based compensation						$ 5,223,000	$ 5,437,000	$ 11,635,000	$ 10,830,000
Fair value of options vested						$ 1,461,000		$ 1,771,000
2005 Employee Stock Option and Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Common stock reserved for issuance														4,800,000
Outstanding stock options						84,200		84,200
2015 Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Common stock reserved for issuance											3,575,000	6,000,000
Common stock reserved													11,500,000
Shares available for future grant						1,506,567		1,506,567
Inducement Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Common stock reserved for issuance						1,500,000		1,500,000
Shares available for future grant						12,386		12,386
Employee Share Purchase Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Common stock reserved for issuance				4,000,000		3,175,733		3,175,733
Total share-based compensation						$ 129,000	140,000	$ 330,000	304,000
Maximum percentage of gross payroll deduction				15.00%
Purchase price as a percentage of fair market value				90.00%
Maximum shares purchase in a single transaction				1,500
Maximum amount purchased in a calendar year				$ 25,000
Shares issued						824,267		824,267
Employee Stock Options
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Outstanding stock options						1,618,864		1,618,864
Total share-based compensation						$ 290,000	627,000	$ 999,000	1,359,000
Total unrecognized compensation costs						$ 386,000		$ 386,000
Stock option recognized over weighted average period (in years)								3 months 18 days
Employee Stock Options | 2005 Employee Stock Option and Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expiration period (in years)								10 years
Share-based compensation award plan , expiration date								May 25, 2015
Employee Stock Options | 2015 Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expiration period (in years)								10 years
Restricted Stock
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based compensation arrangement by share-based payment award, non-option equity instruments, outstanding, number						1,815,406		1,815,406
Restricted Stock | Inducement Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based compensation arrangement by share-based payment award, non-option equity instruments, outstanding, number						1,037,614		1,037,614
Performance Stock Units
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock option recognized over weighted average period (in years)								2 years 4 months 24 days
Total unrecognized compensation costs						$ 9,577,000		$ 9,577,000
Performance Stock Units | Units Granted on September 2021
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total share-based compensation						50,000
Share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures	450,000
Weighted-average grant date fair value	$ 10.52
Performance period	5 years
Award continued service period	3 years
Performance Stock Units | Units Granted On October 2020
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total share-based compensation						575,000		514,000
Share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures		408,861
Percentage of shares issued, minimum		8.50%
Percentage of shares issued, maximum		199.50%
Weighted-average grant date fair value		$ 16.25
Percentage of performance stock units tied to fiscal year 2022 revenue goal		80.00%
Vesting period for the 3-year total shareholder return		3 years
Percentage of performance stock units tied to fiscal year 2023 revenue goal		20.00%
Performance Stock Unit Awards | Units Granted On October 2018
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total share-based compensation						63,000	114,000		229,000
Share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures			248,140
Percentage of shares issued, minimum			50.00%
Percentage of shares issued, maximum			200.00%
Weighted-average grant date fair value			$ 17.84
Percentage of performance stock units tied to 3-year total shareholder return			34.00%
Percentage of performance stock units tied to fiscal year 2021 revenue			33.00%
Percentage performance stock units tied to fiscal year 2021 adjusted earnings per share goals			33.00%
Allocated share-based compensation benefits								375,000
Performance Stock Unit Awards | Units Granted On December 2019 and January 2020
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total share-based compensation						$ 226,000	344,000		625,000
Share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures					279,587
Percentage of shares issued, minimum					42.50%
Percentage of shares issued, maximum					172.50%
Weighted-average grant date fair value					$ 16.02
Allocated share-based compensation benefits								$ 231,000
Percentage of performance stock units tied to fiscal year 2021 revenue goal					80.00%
Percentage of performance stock units tied to fiscal year 2022 revenue goal					20.00%
Vesting period for the 3-year total shareholder return					3 years
Performance Stock Unit Awards | Inducement Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based compensation arrangement by share-based payment award, non-option equity instruments, outstanding, number						450,000		450,000
Restricted Stock
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based compensation arrangement by share-based payment award, non-option equity instruments, outstanding, number						2,853,020		2,853,020		2,263,569
Total share-based compensation						$ 3,889,000	$ 4,150,000	$ 10,347,000	$ 8,189,000
Stock option recognized over weighted average period (in years)								2 years 3 months 18 days
Total unrecognized compensation costs						$ 35,632,000		$ 35,632,000
Share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures								1,605,649
Restricted Stock | Minimum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting period								1 year
Restricted Stock | Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting period								3 years

Share Based Awards - Summary of

Share Based Awards - Summary of Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	6 Months Ended	12 Months Ended
	Sep. 30, 2021	Mar. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Number of Shares, Outstanding, Beginning	2,791,084
Number of Shares, Exercised	(1,010,700)
Number of Shares, Forfeited/Canceled	(20,820)
Number of Shares, Expired	(56,500)
Number of Shares, Outstanding, Ending	1,703,064	2,791,084
Vested and expected to vest, September 30, 2021	1,671,176
Exercisable, September 30, 2021	1,502,682
Weighted- Average Exercise Price per Share
Weighted-Average Exercise Price per Share, Outstanding, Beginning	$ 14.47
Weighted-Average Exercise Price per Share, Exercised	13.41
Weighted-Average Exercise Price per Share, Forfeited/Canceled	21.08
Weighted-Average Exercise Price per Share, Expired	18.85
Weighted-Average Exercise Price per Share, Outstanding, Ending	14.88	$ 14.47
Vested and expected to vest, September 30, 2021	14.87
Exercisable, September 30, 2021	$ 14.85
Weighted- Average Remaining Contractual Life (years)
Outstanding	3 years 4 months 24 days	3 years 8 months 12 days
Exercised	3 years 2 months 12 days
Forfeited/Canceled	4 years 8 months 12 days
Vested and expected to vest, September 30, 2021	3 years 4 months 24 days
Exercisable, September 30, 2021	3 years 2 months 12 days
Aggregate Intrinsic Value
Outstanding	$ 309	$ 10,303
Exercised	1,618
Vested and expected to vest, September 30, 2021	309
Exercisable, September 30, 2021	$ 307

Share Based Awards - Summary _2

Share Based Awards - Summary of Non-vested Stock Option (Details)	6 Months Ended
	Sep. 30, 2021$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Non-vested, Number of Shares [Roll Forward]
Non-Vested Number of Shares, Beginning Balance | shares	459,339
Non-Vested Number of Shares Vested | shares	(248,957)
Non-Vested Number of Shares Forfeited/Canceled | shares	(10,000)
Non-Vested Number of Shares, Ending Balance | shares	200,382
Share-based Compensation Arrangement by Share-based Payment Award, Options, Non-vested, Weighted Average Grant Date Fair Value [Abstract]
Weighted-Average Grant-Date Fair Value per Share, Non-vested, Beginning | $ / shares	$ 5.96
Weighted-Average Grant-Date Fair Value per Share, Vested | $ / shares	5.87
Weighted-Average Grant-Date Fair Value per Share, Forfeited/Canceled | $ / shares	8.74
Weighted-Average Grant-Date Fair Value per Share, Non-vested, Ending | $ / shares	$ 5.94

Share Based Awards - Summary _3

Share Based Awards - Summary of Restricted Stock Awards Activity (Details) - Restricted Stock	6 Months Ended
	Sep. 30, 2021$ / sharesshares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of Shares Outstanding Beginning Balance | shares	2,263,569
Granted | shares	1,605,649
Vested | shares	(871,842)
Canceled | shares	(144,356)
Number of Shares Outstanding Ending Balance | shares	2,853,020
Weighted Average Grant-Date Fair Value per Share, Beginning of Period | $ / shares	$ 14.58
Weighted Average Grant-Date Fair Value per Share, Granted | $ / shares	15.46
Weighted Average Grant-Date Fair Value per Share, Vested | $ / shares	14.98
Weighted Average Grant-Date Fair Value per Share, Canceled | $ / shares	14.74
Weighted Average Grant-Date Fair Value per Share, End of Period | $ / shares	$ 14.95

Commitments, Guarantees and C_2

Commitments, Guarantees and Contingencies - Additional Information (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Sep. 30, 2021
Loss Contingencies [Line Items]
Applicable program documentation period		365 days
Mr.Hussein
Loss Contingencies [Line Items]
Indemnification expenses, paid	$ 11,370

Restructuring Plan - Additional

Restructuring Plan - Additional Information (Details) - USD ($) $ in Thousands	6 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Restructuring Costs [Abstract]
Restructuring costs	$ 539	$ 2,562